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 Glycosaminoglycans (GAGs) are long linear polysaccharides made of disaccharide 
repeats.  The GAGs heparan and chondroitin are found ubiquitously on cell surfaces in many 
organisms and are involved in regulating developmental signaling, immunity, and mediating many 
cell-cell interactions. In Drosophila melanogaster, GAGs are synthesized downstream of the gene 
mummy (mmy), which encodes the Drosophila UDP-N-acetylglucosamine pyrophosphorylase, 
the enzyme performing the final catalytic step in UDP-GlcNAc synthesis.  mmy encodes an 
antagonist of Decapentaplegic (Dpp) signaling, and mmy mutant embryos have expanded ectopic 
Dpp activity in the dorsal epidermis. We confirmed through multiple tests that the mmy-mediated 
effects on Dpp signaling occur downstream of dpp transcription and that mmy activates a switch 
from short-range to long-range signaling in the epidermis. To identify downstream effectors of 
Dpp signal restriction, we screened 23 of the 25 Drosophila β-1,3-glycosyltransferases 
functioning downstream of Mmy. Embryos depleted of either wanderlust (wand), which encodes a 
putative chondroitin sulfate synthase, or super sex combs, which encodes an O-GlcNAc 
transferase, had Dpp activity expanded ectopically beyond the LE epidermis, identifying these 
transferases as a Dpp antagonists.  We further characterized wand and determined that it is 
expressed in embryonic cardiac cells and that it antagonizes Dpp signaling in the mesoderm as 
well as the epidermis.  Taken together, these data suggest that mmy, through wand, synthesizes 
a chondroitin-sulfated sink that alters the signaling range of Dpp.  Future work will involve 
characterizing the role of other chondroitin sulfate-synthesizing genes in Drosophila signaling 
regulation, determining the nature of the Dpp-chondroitin interaction, exploring the role of 
chondroitin sulfate in imaginal disc and testes signaling, and identifying the specific GAG-
modified targets that enact epidermal signal regulation.  These data will provide new insights into 
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THE FUNCTION OF GLYCOSAMINOGLYCANS IN SIGNAL REGULATION 
 
The role of glycosaminoglycan (GAG) in regulation of extracellular signaling has been 
extensively studied.  GAGs are linear polysaccharides attached to extracellular proteins that are 
found almost ubiquitously on cell surfaces and in extracellular matrix (Abrahamsohn et al., 1975; 
Carey, 1997; Izumikawa et al., 2014; Woods and Couchman, 1998). Many GAGs are found 
enriched on the basement membranes of polarized cells, where they perform special functions 
(Hassell et al., 1980; Kanwar and Farquhar, 1979; Myers et al., 1996).  GAGs interact with 
integrins, cytokines, growth factors, and other molecules to enable proper development, 
immunity, and homeostasis (Coombe, 2008; Frey et al., 2013; Iida et al., 1998; Jackson et al., 
1997; Johnson et al., 2005; Sirko et al., 2007; Wrenshall and Platt, 1999).  Three types of linear 
GAG modifications are observed in nature: heparan sulfate (HS), chondroitin sulfate (CS), and 
dermatan sulfate (DS) (Bülow and Hobert, 2006). 
 
Synthesis and subsequent modification of GAGs 
Synthesis of GAGs requires a number of specific enzymes (reviewed in Bülow and 
Hobert, 2006).  Synthesis begins with addition of the GAG-protein linker region, a tetrasaccharide 
that is common to all three forms of GAG.  The GAG-protein linker region, which consists of 
GlcA(β1-3)Gal(β1-3)Gal(β1-4)Xyl β1-O-Ser, is synthesized by stepwise addition of four sugars by 
the sequential action of four sugar transferases (Sugahara and Kitagawa, 2000).  Xylose is 
attached to serine residues on the core protein by xylosyltransferase, galactose in a β1-4 linkage 
by galactosyltransferase I, galactose in a β1-3 linkage by galactosyltransferase II, and glucoronic 





CS chains each requires two different enzymatic activities: GlcA transferase and GalNAc 
transferase for HS polymerization and GlcA transferase and GlcNAc transferase for CS 
polymerization.  These activities are contained within the same protein in the case of CS 
polymerization; Chondroitin sulfate synthase-1 and Chondroitin sulfate synthase-2 are dual 
functioning, having enzymatic domains to carry out both GlcA and GalNAc transfer (Kitagawa et 
al., 2001; Yada et al., 2003a).  DS is not polymerized in this fashion, but is generated from mature 
CS polymers. 
GAG chains are modified subsequent to polymerization, forming a wide diversity of 
sulfated disaccharides through the modification by sulfotransferases and sulfatases (Bülow and 
Hobert, 2006).  These modifications contribute substantial complexity to GAG structure, in excess 
of the structural diversity of nucleotides and peptides.  CS, for example, can be modified at C-2 of 
uronic acid residues, as well as at C-4 and C-6 of GalNAc residues; each repeating disaccharide 
unit may have between zero and three of these potential modifications (Figure 1.1).  Organisms 
can vary greatly in potential GAG diversity.  CS from Drosophila has a low amount of sulfation 
(and only occurring on C-4 of GalNAc), while C. elegans lacks sulfated chondroitin altogether and 
even lacks homologous enzymes to carry out the reaction (Toyoda et al., 2000).  In some 
organisms CS can be converted to dermatan sulfate by the activity of chondroitin-glucuronate C5-
epimerase (EC 5.1.3.19), though dermatan sulfate is not present in Drosophila (Maccarana et al., 
2006).  The presence of any iduronic acid in the GAG chain is sufficient for it to be characterized 
as DS, and CS must contain glucuronic acid exclusively (Béchard et al., 2001).  The enzymes 
that perform sulfation of CS in Drosophila have not yet been identified, but BLAST analysis 
indicates that CG31743 has the highest homology to human Carbohydrate sulfotransferase 13, 
which is required to synthesize CS-A (Kang et al., 2002). 
 
Sulfation affects proteoglycan function 
The sulfation pattern of GAGs is integral to their function and activity.  For instance, 
mutants for the Drosophila gene sulfateless, which is required to add sulfates to CS and HS 






Figure 1.1.  Modification of CS.  Individual naked chondroitin sulfate disaccharides (CS-O) can 
be modified by one of three enzymes.  Glucoronyl C5-epimerase converts CS-O to dermatan 
(Tiedemann et al., 2001); dermatan has its own subsequent modifications that are not covered 
here.  Sulfation of CS-O by C6-sulfotransferase forms CS-A (Habuchi et al., 1993).  CS-A can be 
further sulfated by Uronyl-2-sulfotransferase to form CS-D (Kobayashi et al., 1999).  A separate 
modification branch is initiated by sulfation of CS-O by C4-sulfotransferase to form CS-C 
(Yamauchi et al., 2000).  CS-C can be further sulfated by 4S-6-sulfotransferase to generate CS-E 




particular mutants of FGF-receptors heartless and breathless (Lin and Perrimon, 1999) .   
 Sulfateless is a N-deacetylase-N-sulfotransferase that modifies HS chains by removal of 
acetyl groups from N-acetyl-glucosamine and replacing it for sulfate (Lin and Perrimon, 1999). 
These results suggest that changes in sulfation pattern can promote or abolish interactions with 
other molecules; furthermore, desulfation might be a tool utilized by organisms to dynamically 





The unique structure of GAG allows it to interact with many molecules 
After completion of polymerization and modification, the resultant GAG is one of the most 
negatively charged molecules in the organism.  The unique structure and charge of GAGs enable 
them to interact with a number of growth factors, signaling molecules, enzymes, and many viral 
and bacterial proteins (Rostand and Esko, 1997; Salmivirta et al., 1996).  Due to their ubiquity 
and structure, many bacteria, viruses, and parasites have developed methods to exploit GAGs to 
facilitate attachment, invasion, and colonization of host organisms (Rostand and Esko, 1997).  
Some bacteria have even developed mechanisms to release GAGs from cell surfaces in order to 
inactivate innate antimicrobial defenses (Schmidtchen et al., 2001).  Because of the high amount 
of negative charge found on GAG chains, interactions with other molecules are often, but not 
exclusively, ionic in nature (Salmivirta et al., 1996).  As GAGs carry a large negative charge, 
proteins that interact with them tend to have a large cluster of positively charged amino acids in 
the binding site (Salmivirta et al., 1996).   
 
The roles of GAGs in developmental signaling 
The function of HS in developmental signaling 
The role of GAGs in extracellular signaling was first suggested by genetic screens in 
Drosophila.  Screens for zygotic lethal genes led to the isolation of pattern formation mutants, 
including the signaling morphogen genes wingless (wg) and hedgehog (hh) (Perrimon et al., 
1996).  Wingless (Wg) and Hedgehog (Hh) exhibit a very specific ventral larval cuticle defect in 
which the naked cuticle is lost from the ventral cuticle, resulting in a continuous lawn of ventral 
denticles (Bejsovec and Wieschaus, 1993).  However, these screens also uncovered many other 
genes involved in HS synthesis that shared loss-of-function phenotypes with hh and wg mutants.  
These HS synthesis genes included sugarless, tout-velu, sulfateless, slalom, and dally, which 
encodes an HSPG  (Perrimon et al., 1996); these results suggested a role for HS in regulating 
extracellular developmental signals.  CS synthesis genes have not been as abundantly recovered 
from these screens, perhaps due in part to redundancy among CS synthesizing enzymes. 





mutant for the tout-velu, sister of tout-velu, and brother of tout-velu genes, as well as N-
acetylglucosamine transferases of the EXT family required for biosynthesis of HS chains, have 
decreased Wg, Hh, and BMP homologue Decapentaplegic (Dpp) protein levels and decreased 
signaling activity (Franch-Marro et al., 2005; Han et al., 2004a; Takei et al., 2004).  Wing disc 
clones mutant for sulfateless (sfl), which encodes the heparan sulfate N-acetylase/N-
sulfotransferase, exhibit a similar reduction of protein level and signal activity of these three 
signaling ligands (Belenkaya et al., 2004a; Bornemann et al., 2004; Takei et al., 2004).  
Classical studies of the effects of HS in development have focused on glypicans, heparan 
sulfate proteglycans (HSPG) anchored to the exterior cell membrane by 
glycosylphosphatidylinositol (GPI) (Lin, 2004).  Glypicans are of particular interest for two 
reasons.  First, glypicans play a role as signal cofactors and are involved in many organisms in 
the spreading and activity of Hh, Wnt, and BMP signals (Lin, 2004).  Second, two of the essential 
structural components of glypican, heparan sulfate chains and GPI anchors, require UDP-GlcNAc 
for their synthesis.  Two glypicans, Division-abnormally delayed (Dally) and Dally-like (Dlp), have 
been identified in Drosophila.   
Among studies of GAGs, those of HS have been focused on its interactions with 
extracellular signaling and its roles in early development (Baeg et al., 2001, 2004; Desbordes and 
Sanson, 2003; Fujise et al., 2003; Han et al., 2004b; Rapraeger et al., 1985; Saunders et al., 
1997).  However, studies of CS have been mostly linked to roles in cartilage and bone 
development and health (Gould et al., 1992; Gualeni et al., 2010; Schwartz and Domowicz, 
2002).  Only more recently has focus on CS shifted towards its roles in early development. 
 
The function of CS in developmental signaling 
Many early studies of the role of GAGs in developmental processes focused primarily on 
the role of HS.  Only in about the past 10 years has CS been the focus of developmental 
signaling research.  A landmark study characterized the sqv-5 (squashed vulva-5) gene in C. 
elegans (Mizuguchi et al., 2003).  sqv-5 encodes the C. elegans homologue of human 





growing CS polymer.  Loss of function of sqv-5 results in abnormalities in vulval development, 
possibly due to a requirement for CS in order to create a fluid-filled extracellular space. 
C. elegans have large amounts of chondroitin deposited in oocytes, gonads, uterus, 
spermatheca, and fertilized eggs (Mizuguchi et al., 2003).  (Note that this is unsulfated 
chondroitin, as C. elegans lack sulfotransferases necessary for chondroitin sulfation.)  
Additionally, chondroitin accumulates on the cell surface of cleavage-stage embyos (Mizuguchi et 
al., 2003).  When a Chondroitin Synthase homologue is depleted by RNAi soaking or feeding, 
most oocytes and fertilized eggs die in utero, with escapers having low fertility and malformed 
gonads (Mizuguchi et al., 2003).  At the six cell stage, embryos have a reversal of cell division 
following pseudocleavage, which leads to multinucleated cells and, ultimately, embryonic death.  
These data indicate that CS is required for proper cell division even as early the 4–6 stage of 
embryonic development.  Some single-celled embryos with very low chondroitin sulfate fail to 
initiate cytokinesis, though nuclear division continues; the result is a single-celled embryo with an 
excess of 10 nuclei (Mizuguchi et al., 2003).  Similar results were obtained when cultured 
embryonic cells were treated with chondroitinase ABC; cytokinesis was abnormal, and the cells 
with the greatest reduction in CS were likely to be polyploid (Mizuguchi et al., 2003).  The C. 
elegans squashed vulva (sqv) genes sqv-1 through sqv-8 also play a role in HS and CS synthesis 
in C. elegans.  Progeny of strong loss-of-function sqv homozygous mutants fail to initiate 
cytokinesis at the single celled embryonic stage (Hwang et al., 2003). CS loss cannot be solely 
responsible for these cytokinesis and polarity problems, and there is still much that must be 
learned about effects of CS on polarity in specific contexts.  When Chinese hamster ovary cells 
were mutagenized to elimate HS and CS by targeting xylosyltransferase and galactosyltrasferase 
I, which are required to form the linker tetrasaccharide for CS and HS attachment, these cells did 
not have any defects in cytokinesis (Bai et al., 1999). Regardless, the work of Mizuguchi et al. set 
the stage for investigating the role of CS in early embryonic development and signaling. 
CSPGs are highly expressed in the mammalian neural stem cell niche and play a key 
role in regulating cell fate and self-renewal (Sirko et al., 2007).  When mouse embryonic neural 





Chondroitinase-ABC, which leads to an increase in astrocytes.  In vivo, Chondroitinase-ABC 
injection into the telencephalic ventricle in intrauterine E13 embryos results in a decrease in self-
renewing radial glia and a general reduction in neurogenesis, with accompanying increase in 
astrocytes.  These results might indicate that CSPG plays a role in regulating neural stem cell 
growth and differentiation factors (Sirko et al., 2007). 
 
HS-interacting factors may also interact with CS 
There is considerable overlap between molecules that interact with heparin/HS and those 
that interact with CS; many molecules that are classically considered heparin/HS-binding have 
recently been shown to interact with CS and DS (Mizumoto et al., 2013).  Indeed, hepatocyte 
growth factor is one HS-binding signaling factor shown to bind – and be activated by – DS and 
CS (Lyon et al., 2002).  One study by Deepa, et al. (2002) examined the affinity to CS-E (purified 
from squid cartilage) of several growth factors known to bind to heparin (Deepa et al., 2002).  Of 
all the growth factors tested (which included MK, PTN, FGF-1, FGF-2, HB-EGF, FGF-10, FGF-
16, and FGF-18), only FGF-1 showed no affinity for CS-E.  The affinity of MK, PTN, FGF-16, 
FGF-18, and HB-EGF for CS-E was equal to their affinity for heparin; this demonstrates that GAG 
chains can have both general affinity for growth factors, but in some cases the affinity is highly 
specific, as seen in the case of FGF-1. 
It is, however, important to differentiate between signal binding and signal activation.  A 
recent study investigated the abilities of lowly and highly sulfated chondroitin to interact with 
various growth factors and cytokines (Mizumoto et al., 2013).  Though highly sulfated CS-E has a 
high affinity for VEGF and may play a role in vascularization of some cancers, exactly what that 
role is remains unclear (ten Dam et al., 2007).  The coreceptor for VEGF, Neutrophilin-1, can 
have HS and/or CS attachment, dependent upon the context in which it is expressed.  While both 
modifications result in Neutrophilin-1 having a high affinity for VEGF, only HS modification caused 
an increase in signaling.  These data suggest that increasing CS may change Neutrophilin-1 from 
a coreceptor, which actively facilitates binding of VEGF to VEGFR2,  to a pseudoreceptor or 





study highlights a unique method by which GAG balance can regulate VEGF signaling, as well as 
demonstrates that affinity for GAGs can have positive or negative effects on signaling. 
 
CS interacts with molecules through many mechanisms 
Popular models of CS-signaling protein interaction involve CS acting as a coreceptor, 
assisting in stabilizing molecules on the cell surface so that they may be accessed by their 
receptors (Figure 1.2A) or serving to titrate signaling molecules away from their receptors (Figure 
1.2B).  However, these are not the sole mechanisms whereby CS might affect extracellular 
signaling; the mechanisms by which CS could affect extracellular signaling are diverse.  CS and 
other GAGs might stabilize signaling ligands and protect them from degradation (Figure 1.2C) 
(Akiyama et al., 2008).  To enable FGF signaling, evidence suggests that GAGs assist in FGF 
dimerization (Figure 1.2D) (Ishihara et al., 1993; Walker et al., 1994), whereas for hepatocyte 
growth factor GAG binding induces a conformational change, which allows formation of a ternary 
signaling complex (Lyon et al., 2002).  CS can influence signaling without interacting with a single 
signaling molecule.  CS may function in order to alter the osmotic pressure in the extracellular 
matrix, causing expansion of the area there and altering diffusion of extracellular ligands (Figure 
1.2E) (Comper and Laurent, 1978).  There is also evidence that CS may drive morphogenesis 
embryonic sea urchin development independent of any signaling role, as the osmotic pressure to 
drive epithelial invagination during is driven by secreting CS into the extracellular matrix (Lane et 
al., 1993). 
 
HS and CS synthesis are metabolically linked 
In addition to overlap between binding targets, CS and HS themselves may be able to 
regulate the expression of the other.  There is some evidence that syntheses of CS and HS are 
linked; i.e., inhibition of CS synthesis can result in upregulation of HS synthesis.  Mice mutant for 
N-acetylgalactosaminyltransferase I, which catalyzes the transfer of the first GalNAc onto the 
tetrasaccharide linker, have an upregulation of Ext1 and Ext2, which transfer GlcNAc onto 






Figure 1.2.  Models of signal regulation by CS.  A)  CS acts as a coreceptor to assist ligand-
receptor interaction.  B)  CS binds and titrates the ligand away from its receptors.  C)  CS binding 
stabilizes the ligand and protects it from degradation.  D)  CS serves as a scaffold for assembly of 
ligand dimers or other signaling complexes.  E.  CS expands the space between cells, allowing 






this increase was a result of the metabolic block of CS synthesis or if it was due to a separate 
effect of N-acetylgalactosaminyltransferase I in regulating Ext1 and Ext2 activity (Takeuchi et al., 
2013).  One possibility includes excess UDP-GalNAc resulting in activation of nutrient sensors 
that led to upregulation of Ext1 and Ext2 transcription or translation.  It is notable that this 
increase in HS synthesis only occurred when CS synthesis was blocked, but not when CS was 
destroyed via chondroitinase ABC treatment, indicating that the shift is not due to a sensor of CS. 
 
CS and HS have context-dependent biphasic activities 
The effect of CS or HS on signaling in a particular tissue or organism may be the 
opposite in a different tissue or organism.  However, the nature of signal regulation is organism- 
and tissue-specific; the glypican Dlp is positive for Hh signaling in Drosophila (Gallet et al., 2008), 
yet homologue Glypican-3 has been demonstrated to be a negative regulator of Hh signaling in 
mouse (Capurro et al., 2008).  In Drosophila wing discs, glypicans are required for Dpp diffusion, 
and defects in HS synthesis lead to restriction of Dpp signaling (Fujise et al., 2003).  In contrast, 
the C. elegans glypican Lon-2 has been identified as a negative regulator of BMP signaling 
(Gumienny et al., 2007).   
The exact nature of these context-dependent effects of GAGs on signaling is unknown, 
but as previously noted it could be related to sulfation levels (Mizumoto et al., 2013) or to 
proteoglycan dosage.  Dosage is very important in order for GAGs to have the proper effect on 
extracellular signals, and in many cases loss- and gain-of-function of a particular GAG can have a 
similar influence on signaling.  In zebrafish embryos, chsy1 loss of function (by morpholino 
injection) or gain of function (by injection of human CHSY1 mRNA) both lead to a similar defect in 
semicircular canal development (Li et al., 2010).   
A study on the Xenopus syndecan 1 (xSdc1) further supported this dosage model 
(Olivares et al., 2009).  In particular, it was noted that injection of xSyn1 mRNA into Xenopus 
embryos results in induction of a secondary axis; this phenotype is also observed when BMP 
signaling is reduced.  To test if xSyn1 is acting as a BMP antagonist, xSyn1 mRNA was injected 





was a decrease in P-Smad1 in xSyn1 mRNA injected embryos and also decreased levels of a 
luciferase reporter of BMP-induced transcription.  Similarly, loss-of-function studies of xSyn1 by 
morpholino injections resulted in a loss of luciferase reporter expression, suggesting deviation 
from endogenous xSyn1 levels results in BMP signal antagonism.  
Epistasis experiments indicate that xSyn1 functions upstream of Smad1 and other 
intracellular components of BMP signaling, but downstream of BMP itself (Olivares et al., 2009).  
Interestingly, xSyn1 affects BMP signaling in a bell-shaped curve; when xSyn1 morphant 
embryos are injected with xSyn1 mRNA, low and high concentrations of mRNA have an inhibitory 
effect on BMP signaling, while moderate concentrations of mRNA restore BMP signaling.  xSyn1 
mRNA is able to rescue embryonic dorsoventral patterning and BMP signaling even when its 
GAG attachment sites are mutated, indicating that this activity is carried out by the core protein 
itself and is independent of GAG (Olivares et al., 2009). 
 
CS may play an unappreciated role in BMP signaling regulation 
 The two studies just described suggest that HSPG and CSPG can have biphasic effects 
on BMP signaling.  In the xSyn1 study, BMP signaling was antagonized when xSyn1 was either 
depleted or overexpressed, indicating a role for this HSPG in BMP signal regulation (Olivares et 
al., 2009).  The inner ear phenotypes observed in zebrafish upon altering CHSY1 levels are also 
observed in response to Bmp2b gain of function and loss of function in the developing zebrafish 
ear (Li et al., 2010), suggesting a requirement for chondroitin sulfate to regulate Bmp signaling.  
In Drosophila, HSPGs have been well characterized in their ability to regulate the BMP 
homologue Dpp (Akiyama et al., 2008; Belenkaya et al., 2004a; Fujise et al., 2003; Jackson et al., 
1997; Kirkpatrick et al., 2006a; Makhijani et al., 2007; Nakato et al., 1995; Navas et al., 2006).  
However, far less is known about the role of Drosophila CSPGs in Dpp regulation.  In the 
following chapters I will present evidence indicating a role for CSPG in antagonizing Dpp 
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CHONDROITIN-MEDIATED MODULATION OF DPP SIGNALING IN THE EMBRYO 
 
Abstract 
Mummy (Mmy), a UDP-N-acetylglucosamine pyrophosphorylase that synthesizes UDP-
GlcNAc, functions in the epidermis to limit Dpp signaling, but the precise mechanism of signal 
antagonism remains unclear.  Mmy mutants have reduced protein glycosylation, so we 
hypothesized that a glycosylated protein is the likely antagonist.  To identify the glycosyl-modified 
factor(s) functioning downstream of mmy to enact Dpp signal antagonism, we examined the loss-
of-function cuticle phenotypes of 23 of the 25 Drosophila β-1,3 glycosyltransferases.  From this 
screen we identified wanderlust (wand), a gene with homology to the evolutionarilyconserved 
Chondroitin sulfate synthase 2, and its upstream partner UDP-galactose 4’-epimerase (Gale) as 
antagonists of Dpp.  Gale and wand are expressed in the mesoderm underlying the Dpp-
secreting leading edge cells of the epidermis.  We observed that wand was required not just for 
epidermal signal antagonism, but also for proper mesodermal signaling and dorsal vessel 
development.  Results from our studies point to a role for chondroitin sulfate in converting a long-
range signaling molecule into a short-range one and provide evidence for the first-ever localized 
signaling sink functioning in vivo. 
 
Introduction 
 During embryonic development, numerous embryonic cells differentiate, migrate, and 
divide in coordinated, repeatable patterns.  One mechanism behind this reproducible execution is 
morphogen signaling.  Morphogens were first defined by Alan Turing in his landmark paper, “The 




signaling gradient, wherein differential signal concentrations determine cellular reaction
 (Reviewed in Rogers and Schier, 2011; Turing, 1952).  In 1969, Lewis Wolpert refined our 
understanding of morphogen gradients with the French Flag model, wherein a diffusible ligand 
forms a gradient between a source and distant cells, and cells produce a response that is dictated 
by the local concentration of morphogen the cell perceives (Wolpert, 1969).  Shortly afterwards, 
Francis Crick realized that signal production and spreading will eventually lead to an even 
distribution of signal across all cells and noted that generation of a stable continuous gradient 
requires a “sink,” a signaling component located at a distance from the source that destroys the 
signal (Crick, 1970).  Morphogen gradients could most easily be explained by rapid, free diffusion 
in a closed system with constant destruction of the signaling ligand by a signaling sink.  In time 
the model would be refined, in that in order to form a stable gradient, a sink need not be localized, 
and the effect of ligands binding to their receptors could in fact be sufficient to form a stable 
signaling gradient (Yu et al., 2009); overexpression studies indicated that receptors can serve as 
a sink for their ligands, as indicated by decreased signaling of Drosophila BMP homologue 
Decapentaplegic (Dpp) in cells adjacent to where the receptor Thickveins (Tkv) is ectopically 
increased (Lander et al., 2009; Mizutani et al., 2005).  Additionally, not all morphogens establish 
gradients through the classical source-sink mechanism; the shape of the Bicoid gradient is 
primarily established through mRNA diffusion and distribution (Lipshitz, 2009; Spirov et al., 2009).  
Despite the fact that a localized sink, either near or distant from the signaling source, has 
never been successfully identified in vivo, there is compelling evidence that one might exist.  
Several molecules have been shown to have the ability to bind to extracellular ligands and in 
some cases remove them from the system. With respect to BMP/Dpp signaling, there is evidence 
that the proteoglycan Perlecan serves as a sink for growth factors in the mammalian growth plate 
(Aviezer et al., 1994; Deguchi et al., 2002; Mongiat et al., 2000; Smith et al., 2007).  In 
Drosophila, artificial BMP/Dpp sinks can be created through overexpression of heparan sulfate 
(HS) proteoglycans Dally and Dally-like (Belenkaya et al., 2004b) or overexpression of signaling 
receptors (Lander et al., 2009; Mizutani et al., 2005).  In Drosophila Decapentaplegic (Dpp) 




Drosophila adult testes and ovaries, as well as the leading edge of the mesoderm and epidermis 
during embryonic dorsal closure (Humphreys et al., 2013; Kawase et al., 2004; Shivdasani and 
Ingham, 2003; Song et al., 2004; Yang and Su, 2011)   
In addition to shaping signaling gradients so that positional information can be 
interpreted, signaling sinks may serve additional vital functions.  As signaling morphogens control 
cell growth and differentiation, their misregulation is not surprisingly associated with diseases 
such as cancer and developmental abnormalities such as fibrodysplasia ossificans progressiva 
(Alarmo et al., 2006; Fan et al., 1997; Gobbi et al., 2002; Jin et al., 2001; Kaplan et al., 2006; 
Katoh and Terada, 1996; Li et al., 2010; Nishisho et al., 1991; Polakis, 2012; Singh and Morris, 
2010).  Often the tumorigenic properties of the cancer are reduced when signaling imbalance is 
rectified.  Indeed, in order for survival, signals must often be restricted to the cells that require it 
and kept from those that do not, and signaling sinks may serve a vital role in signal antagonism.  
In the work presented here, I focus on how signaling sinks are utilized to antagonize BMP/Dpp 
signaling in the embryonic development of Drosophila.  
BMPs are an evolutionarily important group of signaling molecules conserved in 
vertebrates and invertebrates, with evidence suggesting a common ancestor at least 600 million 
years ago (Padgett et al., 1993). BMPs were first identified and named for their ability to induce 
bone development (Urist, 1965).  Since their discovery, BMPs have been shown to play roles in 
diverse developmental and morphological processes, including organogenesis (Frasch, 1995; 
Lyons et al., 1990; Mandel et al., 2010; Winnier et al., 1995), wound healing, stem cell 
maintenance (Kawase et al., 2004; Shivdasani and Ingham, 2003; Song et al., 2004; Ying et al., 
2003), and others. 
BMPs are diffusible signaling ligands that form signaling gradients within and between 
tissues and signal through binding to a dimeric receptor complex containing a type II and a type I 
subunit; varying the components of the receptor affects specificity to specific BMP ligands.  When 
the ligand-receptor complex is formed, the type I receptor subunit becomes phosphorylated and 
active.  Phosphorylated type I receptor will then recruit and phosphorylate a Smad signal 




activate and enhance transcription (Massagué, 1998).   
The fruit fly Drosophila melanogaster has been historically useful in studying BMP 
signaling. Many of the evolutionarily conserved proteins involved in activating BMP signaling have 
been identified in Drosophila, due to the recognition of shared loss-of-function cuticle defects of 
signaling components mutated in the Heidelberg screen for mutants affecting the embryonic 
pattern of larval cuticle (Jürgens et al., 1984; Nüsslein-Volhard et al., 1984).  The Drosophila 
epidermis is particularly useful in the study of BMP signaling, as this is where zygotically encoded 
Drosophila BMP homologue decapentaplegic (dpp) is first required, and dpp signaling mutants 
(with the exception of the dpp mutant itself, which has a ventralized phenotype) have well-
characterized and easily identifiable dorsal closure defects (Andrew et al., 1997; Brummel et al., 
1994; Letsou et al., 1995). Dorsal closure is an essential early embryonic process during which 
the laterally positioned epidermal sheets extend to the dorsal midline where they fuse to enclose 
the entire embryo in epidermis.  This extension is a nonmitotic process driven by changes in cell 
shape.  Dorsal closure and similar morphogenetic closure processes in higher eukaryotes are 
initiated and coordinated through conserved, sequentially activated Jun-N-terminal kinase 
(JNK)/AP-1 and Dpp signaling pathways (reviewed in Xia and Karin, 2004). 
Dorsal closure initiates with restricted activation of JNK/AP-1 and dpp expression in the 
leading edge (LE), the dorsal-most cells of the lateral epidermis sheet.  Tight control of JNK/AP-1 
signaling is vital; loss of positive or negative pathway regulators leads to a failure of the epidermis 
to spread dorsally, resulting in incomplete closure.  The success or failure of dorsal closure and 
other embryonic body patterning processes can be evaluated by examining the larval cuticle, an 
exoskeletal layer of chitin and protein secreted by the Drosophila epidermis in a late step of 
embryogenesis.  Loss of function of Drosophila dpp antagonists results in a specific cuticle 
phenotype characterized by hypotrophy of ventral denticle belts and a dorsal hole or pucker due 
to improper dorsal closure.  This phenotype is shared by all Drosophila dpp antagonists studied to 
date, with the exception of brinker (brk), a competitor for binding to Dpp response elements 
functioning more laterally in the epidermis.  brk mutants only exhibit hypotrophy of the ventral 




function cuticle phenotype has been successfully used to identify other antagonists of dpp, 
including raw, ribbon, puckered, and mmy (Byars et al., 1999; Humphreys et al., 2013; Jack and 
Myette, 1997; Ring and Martinez Arias, 1993). 
mmy is distinct from several other dpp antagonists in that its effects are not mediated 
through action of JNK/AP-1 signaling, but are directly on dpp (Humphreys et al., 2013).  mmy 
encodes the single Drosophila UDP-N-acetylglucosamine pyrophosphorylase, an enzyme 
catalyzing the final step of UDP-GlcNAc biosynthesis (Araújo et al., 2005).  Certain mmy 
hypomorphs, such as allele mmy1, exhibit defects in dorsal closure yet have intact chitin, 
signifying that the mmy1 dorsal closure defect stems from an alternative requirement for UDP-
GlcNAc (Humphreys et al., 2013; Tonning et al., 2006).  Aside from chitin synthesis, UDP-GlcNAc 
is utilized for a variety of functions including N- and O-linked glycosylation as well as synthesis of 
glycosyl-phospatidylinostiol, HS, and chondroitin sulfate (CS) (Breitling and Aebi, 2013; 
Hardingham and Fosang, 1992; Low, 1989; Wells et al., 2001). 
There are many diverse ways that UDP-GlcNAc could be utilized downstream of mmy to 
enact Dpp antagonism, and it is the focus of the study presented here to identify the precise 
mechanisms and molecules antagonizing dpp through UDP-GlcNAc utilization.  In this study we 
show that loss of function of CG43313, which we have named wanderlust (wand), suggests a role 
for the CS biosynthetic pathway in Dpp signaling antagonism.  As proteins have already been 
implicated in promoting and antagonizing extracellular signaling, we chose to first focus on 
proteins as the likely antagonist(s).  wand encodes a putative chondroitin sulfate synthase, and its 
restricted expression in embryonic cardiac cells suggests it may function to synthesize a CS sink 
to antagonize Dpp signaling in the epidermis. 
 
Materials and methods 
Drosophila strains 
Fly lines used for this study include w1118, mmy1, mmyP15133, Tub-Gal4 (Bloomington), 
mmyl(2)03851 (M. Krasnow), GaleF00624.4 and Gale∆y (J. Fridovich-Kiel), sdc23 and sdc97 (G. 




Drosophila UAS-shRNA lines (Dietzl et al., 2007) v2598, v2601, v2826, v5027, v6176, v6177, 
v7262, v7263, v7394, v7427, v7949, v8107, v12079, v13474, v16981, v16982, v21761, v26517, 
v29084, v29085, v33366, v33368, v35572, v35573, v42781, v44939, v45194, v45457, v46419, 
v46421, v51977, v100016, v100185, v101307, v101417, v101660, v102288, v104256, v104281, 
v105791, v106134, v106605, v106839, and v107840 (VDRC). 
 
Glycosyltransferase screen 
To identify glycosyltransferases functioning downstream of mmy to enact dpp 
antagonism, we mated Tub-GAL4 virgins to UAS-shRNA males from glycosyltransferase RNAi 
lines to induce early, ubiquitous depletion of maternal and zygotic transferase mRNA.  We then 
compared larval cuticles (described below) to mmy mutant larval cuticles to test for shared loss-
of-function cuticle defects.  The screen included all 25 predicted Drosophila β1,3-
glycosyltransferases  (Correia et al., 2003). 
 
Cuticle analyses 
For embryonic cuticle analysis, animals were dechorionated in 50% bleach solution and 
incubated overnight at 60°C in One-Step Mounting Me dium (30% CMCP-10, 13% lactic acid, 
57% glacial acetic acid).  In some cases embryos were devitellined prior to One-Step Mounting 
Medium incubation by shaking for 1 minute in equal parts methanol and heptane.  Cuticles were 
visualized with dark field microscopy.  
 
Larvae dissections 
To prepare larvae for fixing and staining, 3rd instar wandering w1118 larvae were placed in 
a drop of ice-cold PBS and bisected at the midpoint of the anterior/posterior axis.  The anterior 
half was retained and inverted to expose internal organs and tissues to the solution.  Inverted 
larvae were fixed, washed, hybridized with an digoxigenin-labeled mRNA probe, as described 
previously (Byars et al., 1999). Following staining, individual tissues and organs were dissected 




RNA in situ hybridization 
For in situ hybridization, we generated digoxigenin-labeled probes as described 
previously (Byars et al., 1999). Probes were detected with anti-digoxigenin-AP Fab fragments 
(Roche) and visualized with DIC optics.   
 
Immunolocalization 
Alkaline phosphatase immunolocalization studies were performed as described (Sullivan 
et al., 2000).  Fluorescent Phospho-Mad visualization was performed as previously described 
(Humphreys et al., 2013) using confocal techniques.  For immunolocalization studies, we used 
rabbit anti-Phospho-Smad1,5 Ser463/465 (1:20, Cell Signaling Technology), mouse anti-β-Gal 
(1:500, Promega), goat anti-mouse alkaline phosphatase (1:2000, Promega), goat anti-rabbit 
alkaline phosphatase (1:2000) (Jackson ImmunoResearch), and goat anti-rabbit Alexa Fluor 488 
antibodies (1:200, Invitrogen Molecular Probes). 
 
Western Blotting 
For western blotting studies, control and experimental protein lysates were made from 
embryos 5–17 hours after egg lay (AEL).  Absence of a GFP-marked balancer chromosome was 
used to distinguish mutant homozygote embryos from wild-type siblings.  Protein lysates were 
separated on SDS-acrylamide gel and analyzed by western blotting using anti-Dally-like protein 
antibody (1:1000, Developmental Studies Hybridoma Bank) and mouse anti-Tubulin control 
(1:50000, Amersham).  HRP-conjugated donkey anti-mouse was used as the secondary antibody 
(Jackson ImmunoResearch). Blots were stripped using a mild stripping protocol (Abcam) prior to 
being reprobed for Tubulin control. 
 
Results 
There are a number of glycosyltransferases that function downstream of Mmy to carry out 
glycosyl-modifications.  We hypothesized that loss of function of a transferase that glycosylates a 




phenotype.  To identify the protein(s) modified downstream of Mmy to enact Dpp antagonism, we 
performed an RNAi screen against 23 of the 25 predicted Drosophila β-1,3 glycosyltransferases 
(Correia et al., 2003) and screened the embryos for the cuticle defect exhibited in mmy1 mutant 
embryos (Table 3.1) (Humphreys et al., 2013; Nüsslein-Volhard et al., 1984).  Loss of function of 
a single glycosyltransferase, encoded by CG43313, exhibited a cuticle defect similar to that seen 
in mmy1 mutants (Figures 3.1C and 3.1E), suggesting that this transferase modifies a protein 
involved in Dpp antagonism.  This CG43313-encoded transferase, which we have named 
Wanderlust (Wand), is homologous to human Chondroitin sulfate synthase 2 (Yada et al., 2003a) 
(Figure 3.2) and is predicted to function in utilizing UDP-GalNAc to synthesize chondroitin.   
Next we tested if mmy hypomorphic alleles have sufficient loss of UDP-GlcNAc synthesis 
to result in glycosylation defects; for this purpose, we used western blot analysis to analyze shifts 
in molecular weight of Dally-like protein (Dlp), a HS proteoglycan consisting of a protein core of 
85 kDa weight and attached HS chains of variable lengths (Figure 3.3).  In wild-type embryonic 
lysates, HS-modified Dlp appears as a broad band in the 130–160 kDa range of the blot, whereas 
in two independently generated mmy hypomorphs the Dlp band shifted to average 100 kDa; 
these data suggest truncation in HS chain length in mmy mutants and confirm that hypomorphic 
alleles of mmy exhibiting Dpp signaling abnormalities have insufficient UDP-GlcNAc synthesis in 
order to carry out full glycosylation.  Additionally, we noted that the intensity of the Dlp band was 
decreased in mmy mutant embryos, though whether this Dlp decrease is due to a decrease in 
translation, an increase in degradation, or a lesser affinity of the anti-Dlp antibody for Dlp with 
truncated HS chains is unknown. 
There are two lethal alleles of wand (CG43313PL61 and CG43313PL69) that were 
generated by P-element insertion into the gene region (Bourbon et al., 2002).  We tested these 
alleles for phenotypes characteristic of ectopic dpp expression, but as mutant animals die in the 
larval stage, they did not reproduce the mmy cuticle phenotype, nor did they have expanded dpp 
transcription (data not shown).  This may be due to a high level of maternal deposition of wand or 
to a hypomorphic nature of the alleles (Figure 3.4D).  Chondroitin synthesis lies downstream of 




Table 3.1 – β-1,3 glycosyltransferase genes screened for mmy-like cuticle phenotypes 
Gene name Transformant ID Viability Cuticle phenotype 
C1GalTA 2826 semi-lethal wt 
CG8708 8107 Viable - 
 45194 viable - 
CG2975 2601 viable - 
CG3119 2598 viable - 
 105791 viable - 
twg 6176 viable - 
 6177 viable - 
CG34056 7427 viable - 
CG34057 21761 viable - 
CG18558 33366 semi-lethal wt 
 33368 viable - 
CG9220 29084 viable - 
 29085 viable - 
 106839 lethal wt 
β3GalTII 7949 viable - 
 106134 viable - 
CG9109 16981 lethal misformed denticles, 79/212 embryos 
 16982 lethal no cuticle, 0/95 embryos 
 100016 lethal wt 
brn 44939 lethal wt 
 45457 lethal wt 
CG11357 5027 viable - 
 108467 semi-lethal wt 
CG8673 100185 viable - 
 100185 viable - 
CG33145 7394 viable - 
 104256 lethal wt 
CG30037 12079 viable - 
 13474 viable - 
 101660 viable - 
CG30036 101307 viable - 
CG3038 35572 viable - 
 35573 viable - 
CG2983 7262 viable - 
 7263 viable - 
 104281 lethal wt 
wand 26519 semi-lethal mmy-like, 35/60 cuticles 
GlcAT-I 107840 lethal wt 
 46421 viable - 





Figure 3.1.  Chondroitin sulfate synthesis is required for Dpp antagonism. (A).  Biochemical 
pathway for converting GlcNAc-1-P to chondroitin.  Larval cuticles, dpp mRNA, and Mad 
phosphorylation in embryos with chondroitin sulfate synthesis defects.  (B) A wild-type cuticle.  
(C) A mmy1 mutant cuticle has a dorsal pucker, germband retraction and head involution defects, 
and hypotrophy of the ventral denticle belts.  This phenotypes is shared by loss-of-function of 
downstream genes (D) Galactose epimerase (Gale), which converts UDP-GlcNAc to UDP-
GalNAc, and (E) wand, which encodes a putative chondroitin sulfate synthase.   This shared 
cuticle phenotype is indicative of ectopic dpp in the epidermis. (F–I) dpp in situ in stage 13 
embryos.  (F) Lateral view of a wild-type embryo.  dpp expression is restricted to the single row of 
leading edge epidermal cells during dorsal closure.  Expansion of dpp transcription into the 
dorsolateral epidermis is observed in (G) mmy1, (H) GaleF00624.4, and (I) CG43313 embryos.  (J–
M) Phospho-Mad in the epidermis of Drosophila embryos, single slices.  (K) mmy1 and (L) 
GaleF00624.4 mutants, and (M) wand RNAi embryos have an expansion of Dpp signaling activity 










Figure 3.2.  Wand is homologous to Chondroitin sulfate synthase 2.  Multiple sequence 
alignment between Chondroitin sulfate synthase 2 (M. musculus), Chondroitin sulfate synthase 2 
(H. sapiens), CG43313 (D. melanogaster), and Chondroitin sulfate synthase 2 (C. elegans).  
Sequences were aligned using ClustalX 2.1 (Larkin et al., 2007), and the alignment was shaded 





Figure 3.3.  mmy hypomorphs have defective glycosylation.  Western blot analysis of Dally-
like protein (Dlp).  Dlp consists of a core protein with molecular weight 85 kDa, which is post-
translationally modified by glycosylation with heparan sulfate chains of variable length.  The 
glycosylated protein appears as a smear of products of approximate molecular weight 130–160 
kDa. The core protein is denoted by the black arrow in the sugarless lane, as sugarless is 
required to initiate heparan sulfate attachment; the presence of glycosylated Dlp is likely the 
product of enzyme translated from maternal mRNA.  A reduction in Dlp molecular weight is 
observed in two independently generated hypomorphic mmy mutants, suggesting decreased 
availability of UDP-GlcNAc for posttranslational glycosylmodifications; there is also a generalized 




due to a loss of chondroitin, we turned to the gene directly upstream of wand in the chondroitin 
biosynthesis pathway.  The Drosophila gene UDP-galactose 4'-epimerase (Gale) is required to 
convert UDP-GlcNAc into UDP-GalNAc (Sanders et al., 2010), the substrate of chondroitin sulfate 
synthases. Given this, genetic and biochemical models predict that Gale mutant embryos would 
have the same loss-of-function cuticle defects as mmy embryos.  When tested, this prediction 
held true (Figure 3.1D); the shared cuticle phenotypes of three consecutive enzymes in the CS 





Figure 3.4.  Embryonic expression patterns of Gale and wand.  Gale mRNA (A) is not 
maternally deposited. (B) Expression behind the epidermal leading edge initiates during 
embryonic stage 11, (C) but diminishes by stage 13.  wand mRNA (D) is maternally deposited.  
(E) Cardiac expression of wand initiates during stage 12 and continues through (F) stage 13 of 
embryogenesis. (G–I) A comparison of tissue expression of three transcripts, (G) tinman, a 
cardiac marker; (H) wand; and (I) zfh1, a pericardial cell marker.  (G’–I’) Black arrows denote the 
epidermal leading edge, whereas the white arrow depicts the location of mRNA transcript in situ.  
The gap distance between the two arrows is similar in tinman and wand in situs, suggesting that 




enacting Dpp antagonism.   
To further characterize the roles of these genes in dpp antagonism, we examined the 
expression of dpp transcript in Gale mutant and wand RNAi embryos.  In analysis of dpp 
transcript in situ, we noted that Gale mutant and wand RNAi embryos, like mmy1 mutant embryos, 
exhibit ectopic dpp expression in the dorsolateral epidermis (Figures 3.1F–3.1I). Furthermore, 
wand RNAi embryos exhibit ectopic dpp expression overlying the peripheral nervous system and 
in the head fold, suggesting a general role in Dpp antagonism that is not restricted solely to the  
leading edge of the epidermis (Figure 3.1I). 
To test if ectopic dpp expression is associated with a corresponding expansion of Dpp 
signaling fields, we probed Mad phosphorylation (P-Mad) in embryos, as P-Mad is the transducer 
of the Dpp signal (Hoodless et al., 1996).  We observed that P-Mad-positive Dpp signaling fields 
were expanded in Gale mutants and wand RNAi embryos, in a similar manner of expansion found 
in mmy mutants (Figures 3.1J–3.1M). 
We next examined the expression of Gale and wand to determine if their localization 
might suggest a mechanism of signal antagonism.  To test if Gale and wand are expressed in a 
time and location consistent with a function in dorsal closure, we examined the embryonic 
localization of said mRNA transcripts in situ.  We noted that Gale is not maternally deposited 
(Figure 3.4A), but is expressed near the LE epidermis during germband extension (Figure 3.4B); 
the quantities and timing of Gale and wand expression are consistent with measures reported in 
the modENCODE database (Graveley et al., 2011).  During dorsal closure, Gale is absent from 
the leading edge, though staining in the salivary glands is prominent (Figure 3.4C).  wand is 
maternally deposited in the early syncytial blastoderm, but zygotic expression is first noted in a 
similar pattern to Gale expression during germband extension and continuing in expression near 
the leading edge through dorsal closure.  A closer comparison of wand expression and 
expression of the cardiac enhancer B2-3-20 suggested that it is expressed in the cardiac cells 
(data not shown), although we could not rule out the possibility that wand is instead restricted to 
pericardial cells.  To distinguish between these two potential locations of expression, we 




marker (Figures 3.4G–3.4I) (Lockwood and Bodmer, 2002; Su et al., 1999).  wand and tinman are 
similarly expressed, placing wand expression in the cardiac cells of the developing Drosophila 
heart, a tissue that in fact contacts the epidermal leading edge and requires Dpp for its 
specification (Frasch, 1995).  To further characterize wand and identify other areas where CS 
might play a role in signal regulation, we examined mRNA localization of wand in Drosophila 
larvae.  We observed that wand is absent from most larval tissues (data not shown).  However, 
there is mRNA expression in all imaginal discs, as well as in the gastric caeca (Figures 3.5A and 
3.5B).   
As wand and tinman are similarly expressed in the cardiac cells, we next tested if they 
were under similar transcriptional regulation.  tinman expression in the mesoderm is dictated by 
Dpp signaling and under indirect control of upstream JNK/AP-1 in the leading edge epidermis 
(Frasch, 1995; Xu et al., 1998; Yin and Frasch, 1998).  In order to test if wand expression was 
similarly under control of JNK/AP-1 or Dpp signaling, I probed wand expression in wild-type, 
JraIA109, mmy1, and rawIG mutant embyros.  Tinman expression is expanded in the mesoderm in 
rawIG mutants, whereas tinman mRNA is absent or reduced in cardiac cells in JraIA109 mutants 
(Lockwood and Bodmer, 2002; Yang and Su, 2011). We noted that wand expression is 
maintained in the cardiac cells in all genetic backgrounds tested (Figures 3.5C–3.5E), indicating 
that expression of wand is independent of activity of JNK/AP-1 and Dpp. 
The cardiac-restricted expression pattern of wand is consistent with the localized 
expression of CS proteoglycans Syndecan (Sdc), Terribly reduced optic lobes (Trol), Kon-tiki, and 
Multiplexin, which are expressed in embryonic cardiac cells (Friedrich et al., 2000; Hammonds et 
al., 2013; Knox et al., 2011; Medioni et al., 2008; Momota et al., 2011; Tomancak et al., 2007).  
This expression pattern suggests that the wand-dependent mechanism to antagonize epidermal 
Dpp in fact originates in the mesoderm, and direct contact with the Dpp source suggests a 
potential model for a CS proteoglycan manufactured in the cardiac cells to act as a localized Dpp 
sink to prevent Dpp reaching sufficient thresholds in the epidermis to drive Dpp autoregulation 
(Figure 3.6) (Crick, 1970; Humphreys et al., 2013; Johnson et al., 2003).  When the sink is lost 





Figure 3.5.  Expression of wand in 3rd instar larvae and transcriptional control of wand in 
embryos.  (A) wand mRNA is expressed in the gastric cecae (GC), but is absent from the rest of 
the foregut and midgut, including the proventriculus (P). (B) wand mRNA is also present in 
imaginal discs, such as this wing disc.  wand remains restricted to the cardiac cells (and its 




sufficient quantities to drive Dpp autoregulation and expand dpp transcription.   
sdc and trol have both been implicated in BMP and/or Dpp signaling in other contexts 
(Fisher et al., 2006; Lindner et al., 2007), making them especially attractive candidates for an 
epidermal Dpp signaling antagonist.  A sink for epidermal Dpp could also function as an 
antagonist of Dpp signaling in the mesoderm.  To test this, we examined the specification of 
embryonic cardiac cells, labeled by the B2-3-20 enhancer trap (Figure 3.7A) (Bier et al., 1989).  
sdc is required for proper cardiac cell specification, a phenotype which is enhanced in dpp mutant 
heterozygotes (Knox et al., 2011).  In sdc mutants, there is a failure to specify cardiac cells in 
embryonic hemisegments (Figure 3.7B), and this loss is sensitive to Dpp levels (Knox et al., 
2011).  Loss of function of raw, an antagonist of JNK in the epidermis (Bates et al., 2008; Byars et 
al., 1999) leads to overspecification of cardiac cells during dorsal closure due to ectopic Dpp 
signaling (Figure 3.7C) (Yang and Su, 2011). mmy mutants, despite ectopic epidermal dpp 





Figure 3.6.  Model for CS-mediated embryonic Dpp antagonism.  (A)  Dpp secreted from the 
leading edge of the epidermis.  It signals back to the leading edge cell to promote further dpp 
transcription and to the mesoderm to specify cardiac cell fate.  Chondroitin sulfate, synthesized in 
the mesoderm, prevents excess Dpp signal from reaching the dorsolateral epidermis and 
mesoderm.  (B)  If the chondroitin sulfate sink is lost, Dpp access to dorsolateral epidermis and 
mesoderm are unrestricted; excess signaling results in ectopic dpp transcription and ectopic 




exhibit a cardiac gap  phenotype reminiscent of sdc mutants (Figure 3.7D).  We suspect that this 
is the result of decreased HS and CS synthesis in mmy mutants leading to defective sdc 
glycosylation and signaling function, as sdc is a necessary cofactor of mesodermal dpp signaling 
(Knox et al., 2011).  wand RNAi embryos, on the other hand, have cardiac cell gain (Figure 3.7E), 
reminiscent of raw embryos, which have too much Dpp signaling in the mesoderm (Klinedinst and 
Bodmer, 2003; Yang and Su, 2011).  In this case, wand loss of function depletes the sink 
molecule CS, while leaving HS-modified Sdc intact to carry out necessary mesodermal Dpp 
signaling and cardiac specification.signaling and cardiac specification. 
We tested the roles of sdc and trol both singly and together in antagonizing epidermal 
Dpp through analysis of mutant larval cuticles.  The role of sdc in mesodermal Dpp signaling plus 
its expression in cardiac cells makes it an attractive candidate as the mesoderm-expressed Dpp 
sink.  However, sdc mutant embryos do not have cuticle defects associated with ectopic dpp 






Figure 3.7.  Cardiac cells, visualized with anti-β-galactosidase. (A) Cardiac cells in a wild-
type embryo; these cells lie direcly underneath the LE epidermis.  (B) Hemisegment loss of 
cardiac cells occurs in sdc23 mutants.  Genetic interactions between sdc and dpp mutants 
suggest that sdc, possibly in concert with Dpp signaling, is required for cardiac specification. (C) 
raw1 mutants exhibit overspecification of cardiac cells due to ectopic Dpp signaling.  (D) mmy1 
mutants have hemisegment loss of cardiac cells, similar to sdc mutants.  This may be a result of 
mmy mutants having defective sdc function.  (E) Tub-wand shRNA embryos have 
overspecification of cardiac cells.  The differences in mmy1 and wand shRNA phenotypes may be 
due to the fact that mmy mutants have disrupted sdc function due to loss of both CS and HS. Sdc 
in Tub-wand shRNA embryos would have decreased CS attachment, but would retain HS and be 







while sdc is an important effector of mesodermal Dpp signaling, it is not the Dpp sink.  Similarly, 
trol mutant embryos did not exhibit cuticle defects associated with ectopic Dpp signaling, nor did 
we observe ectopic expression of dpp in the epidermis (data not shown).  Last, we tested if the 
signal antagonist may not be tied to any particular protein, but is due to a combination of CS-
modified proteins; thus, the overlapping cardiac expression domains of sdc and trol could 
compensate for the loss of one or the other.  To test this model, we examined cuticle phenotypes 
and dpp expression in trol sdc double mutant embryos.  While nearly 50% of double mutant 
animals failed to deposit a cuticle, we did not observe mmy-like cuticles or dpp expansion in trol 
mutants, sdc mutants, or trol sdc double mutants in excess of background levels (data not 
shown). We did not study the effects of kon-tiki or multiplexin loss of function, so one of these CS 
proteoglycans might still have a role in Dpp signal antagonism.  The exact CS-modified protein(s) 
that enable the sink has yet to be identified. 
 
Discussion 
In this study, we have shown evidence of the first genetically defined localized signaling 
sink that converts a long-range signaling molecule into a short range one and have identified 
wand and Gale as Dpp signaling antagonists.  These data suggest that CS is an important 
molecule functioning in early Drosophila development.  Drosophila are reported to have high 
chondroitin-4-sulfate expression in ovaries (Pinto et al., 2004)  There is little de novo heparan 
sulfate synthesis in embryos until about 10–12 hours AEL; there is a significant component of CS 
present in the embryo at this point, though whether it is maternally deposited or made de novo is 
unknown (Pinto et al., 2004).  CS-C is only detected in trace amounts in Drosophila larvae, and 
chondroitin during embryonic and adult life is 4-sulfated or unsulfated (Pinto et al., 2004).  CS is 
more prevalent than heparan sulfate at all stages in Drosophila development, having nearly equal 
levels in embryos, and approximately 20:1 and 10:1 ratios of CS to HS in 3rd instar larvae and 
adults, respectively (Toyoda et al., 2000). 
We have previously noted in wild-type embryos that Mad phosphorylation rapidly decays 




Interestingly, the onset of expression of wand in the mesoderm adjacent to the leading edge 
coincides with this decay; further work will determine if CS synthesis might be the critical step in 
transitioning epidermal Dpp from a long-range to a short-range signal during dorsal closure.  
Experimental evidence has suggested that altering the heparan/chondroitin balance may be 
important in transitioning CS from a signaling mediator to a signaling sink. Mammalian Perlecan 
is involved in FGF delivery, and it can be modified by CS and HS.  However, FGF is not released 
to its receptor if Perlecan is highly CS-modified; thus, CS may mark the change between a 
signaling effector and a sink in this protein (Smith et al., 2007).  Unlike in the dorsolateral 
epidermis, the wing disc is an area of long-range Dpp signaling (Lecuit et al., 1996; Nellen et al., 
1996; Schwank et al., 2011).  Though wand expression would likely lead to CS synthesis in the 
wing disc, this does not transition to Dpp to a short-range signal in this context; thus the presence 
of CS does not strictly define short-range signaling.   Context is very important in determining the 
interactions between CS proteoglycans and extracellular signaling molecules, and timing, 
dosage, sulfation, and other factors can determine whether the effect of a proteoglycan is 
positive, negative, or neutral on extracellular signals (Bai et al., 1999; Li et al., 2010; Mizumoto et 
al., 2013; Olivares et al., 2009; Shintani et al., 2006). 
The embryonic epidermis is not the only tissue where Dpp signal is restricted to a short 
range.  A similar restriction of Dpp signaling is seen in the stem cell niche of the testis, where Dpp 
expressed in somatic cells of the testes  maintains the germline stem cells (Kawase et al., 2004; 
Michel et al., 2011; Song et al., 2004).  Whether signaling range in this context is restricted by 
chondroitin sulfate is unknown. 
It may at first be surprising that Gale and wand mutants were not generated in the 
Heidelberg screens for mutants affecting the embryonic pattern of cuticle (Jürgens et al., 1984).  
After all, this was the screen that generated alleles of dpp antagonists, including mmy and raw 
(Bates et al., 2008; Byars et al., 1999; Humphreys et al., 2013). This could be due to the fact that 
wand is maternally deposited, and this maternal transcript may be sufficient to complete 
embryonic patterning in the absence of zygotic-encoded wand.  In fact, the two alleles of wand 




mutant embryos might be less severe than those seen in wand RNAi embryos for a few different 
reasons.  First, there is a salvage pathway for hexosamines (including GalNAc) that allows them 
to reenter the pathway downstream of mmy and Gale (Vocadlo et al., 2003).  As wand functions 
downstream of salvage, GalNAc recovered in the salvage pathway would still be blocked from 
being polymerized into CS in the RNAi embryos.   
A second factor could be enzymatic redundancy.  It is notable that wand is not the only 
predicted chondroitin synthase in the Drosophila genome.  CG9220 is predicted to encode an 
enzyme with similar function to wand (Wilson, 2002).  Protein domain prediction identifies a 
chondroitin N-acetylgalactosaminyltransferase domain.  Further study will determine if the 
expression patterns of CG9220 and wand are complimentary or overlapping.  Mice null for wand 
homologue Css2 have no obvious phenotypic or morphological changes, perhaps due to 
redundancy of CS synthesis enzymes (Ogawa et al., 2012).  Indeed, loss-of-function of Css2 
decreases the quantity of CS chains exceeding 10 kDa in weight, but does not affect the total 
number of CS chains attached to core proteins (Ogawa et al., 2012).  Similarly, mutations in Gale 
may have partially penetrant effects due to potentially redundant enzymatic activities from the 
product of CG5955, a predicted UDP-glucose 4-epimerase (Flybase).  However, CG5955 is not 
found in embryos until 16 hours after egg lay, according to the modENCODE RNA expression 
database (Celniker et al., 2009).   
Tangential to the goal of this study was the observation that Dlp levels are decreased 
when glycosylation is inhibited in mmy mutant embryos.  In many cases, glycosylation has been 
demonstrated to be dispensable for the interaction of a proteoglycan and signaling ligands.  The 
C. elegans glypican LON-2 is an antagonist of BMP signaling (Gumienny et al., 2007; Taneja-
Bageshwar and Gumienny, 2012).  LON-2 has two functional domains that are able to bind to 
BMP; the C-terminal domain contains heparan sulfate attachment sites, while the N-terminal 
domain has no attachments but is able to bind to BMP and inhibit signaling independent of the C-
terminal.  In Drosophila the protein Dally does not require HS attachment to complete its role in 
Dpp signaling, though HS does make it more efficient (Kirkpatrick et al., 2006b).  Expression of a 




defects in dally mutant animals, especially in wing formation (Kirkpatrick et al., 2006b).  These 
data are complicated by the fact that the authors were unable to determine how much Dally was 
generated by the rescue construct.  As partial loss of HS chains may decrease glypican stability, 
future studies on the role of HS and CS modification on protein function and interaction should 
take care to ensure that alterations in HS and CS levels do not result in unintended reduction in 
protein stability. Overall, the data presented here indicate that CS production may be utilized to 
create an extremely sharp signaling gradient, and this mechanism may be used in other 
organisms and developmental systems toward the same end.  Increasing CS production might 










FUTURE EXPERIMENTAL PROPOSALS FOR THE STUDY OF CHONDROITIN SULFATE IN 
DEVELOPMENTAL SIGNALING 
 
While much has been published concerning the role of glycosaminoglycans (GAGs) in 
regulation of diverse signaling molecules, including BMPs, these publications have focused 
primarily upon HS (Baeg et al., 2001, 2004; Desbordes and Sanson, 2003; Fujise et al., 2003; 
Han et al., 2004; Rapraeger et al., 1985; Saunders et al., 1997).  Moreover, information 
concerning the role of CS proteoglycans during development has been very limited.  CS 
proteoglycans have potential effects on cytokinesis and polarity as well as neural stem cell 
renewal (Mizuguchi et al., 2003; Sirko et al., 2007), and the work in the previous chapters outlines 
a requirement for CS to antagonize Drosophila Dpp signaling.  CS was not previously known to 
have any direct function in Dpp signaling, and regulation of Dpp signaling through GAGs was 
thought to be mainly carried out by heparan sulfate proteoglycans; Dally in particular is known to 
shape Dpp signaling gradients in wing discs (Akiyama et al., 2008; Desbordes and Sanson, 2003; 
Fujise et al., 2003; Jackson et al., 1997).  That many classical HS-binding factors have recently 
been found to interact with CS (Deepa et al., 2002; Lyon et al., 2002; Mizumoto et al., 2013) 
underscores the necessity for more information about the nature and effects of these interactions.  
Clearly, CS plays a greater role in BMP signaling, and may have applications in treating human 
diseases with abnormal BMP signaling, including fibrodysplasia ossificans progressive (FOP) and 
cancer.
FOP is the best characterized human disease caused by excess BMP signaling.  This 
highly debilitating disease causes the victims’ soft tissues to be slowly ossified to bone in 




(Kaplan et al., 2008).  Though the disease-causing allele can be inherited in an autosomal 
dominant fashion, the majority of FOP cases arise due to de novo mutation.  An R206H mutation 
in the Activin receptor type-1 (ACVR-1) is the cause of most cases (Dinther et al., 2010; Shore et 
al., 2006), though the disease can also result from a frame-shift mutation in the receptor gene 
(Dinther et al., 2010; Fukuda et al., 2008; Kaplan et al., 2008).  In the progression of FOP, ACVR-
1 mutation results in hyperactive BMP receptor activity and a breakdown of BMP negative 
feedback, which results in overproduction of BMP-4 mRNA and protein (Dinther et al., 2010; 
Kaplan et al., 2008).  The use of exogenous heparan or the alteration of endogenous HSPG has 
been suggested as a therapy to quench BMP signaling and reduce the severity of FOP (Jiao et 
al., 2007; O’Connell et al., 2007).  We similarly propose that CS induction may help quench BMP-
4 signaling and lessen tissue ossification postinjury in FOP patients. 
Many cancers have an upregulation of BMP signaling, whether through gain in BMP gene 
copies (Alarmo et al., 2006) or transcriptional regulation (Rothhammer et al., 2005).  In short, 
BMP signals are increased in several cancers, though the effects are BMPs in these cancers can 
either advance or inhibit cancer progression; activity of Dpp homologue BMP-2 especially 
contributes to tumor progression (Singh and Morris, 2010). The processes of angiogenesis and 
metastasis, to which BMPs contribute, are very complex, and the effects of BMPs may be either 
primary or secondary (Singh and Morris, 2010).  We speculate that, as CS plays an important role 
in Dpp signaling regulation in the Drosophila embryonic epidermis, BMP signaling during complex 
processes such as cancer angiogenesis and metastasis may be similarly influenced by CS.  
Though most studies investigating GAG therapy as a treatment for cancer have focused on HS 
and hyaluronan (Yip et al., 2006), there may be unrecognized therapeutic value of chondroitin as 
a molecule to prevent metastasis, growth, or angiogenesis of certain tumor types.  Prior to 
answering the questions of potential CS therapeutics in human BMP disease, we must fully 
understand the interactions between CS and BMP signaling.   
There are four main questions that remain regarding the interaction of chondroitin sulfate 
(CS) with Decapentaplegic (Dpp) signaling antagonism in the Drosophila dorsolateral epidermis.  




direct physical interaction between CS and Dpp?  3)  Does CS function as a Dpp signaling 
antagonist in other contexts during Drosophila development or homeostasis and even in other 
organisms?   4)  What are the specific CS-modified proteins functioning to antagonize Dpp 
signaling in the Drosophila embryonic epidermis?  In this chapter, I will explore potential 
experimental methods to address these questions and the advantages and drawbacks of the 
various protocols. 
 
Procedures for the physical quantification of CS in Drosophila embryos 
Methods for quantification of CS 
 Though BLAST analysis clearly suggests that wanderlust (wand) encodes a chondroitin 
sulfate synthase, I was unable to clearly demonstrate that chondroitin sulfate levels are reduced 
when wand function is depleted in the early Drosophila embryo.  Three different methods were 
utilized in an attempt to quantify Drosophila CS synthesis.  Ultimately, all were unsuccessful.  The 
first attempt was by western blotting utilizing the CS-56 antibody; whether it is able to detect 
chondroitin-4-sulfate (CS-A), which is the sole form of CS that is expressed in D. melanogaster, is 
controversial (Avnur and Geiger, 1984; Pinto et al., 2004; Yi et al., 2012; C. Mencio, personal 
communication, March 2014).  In western blot analysis, I noted that the antibody successfully 
detected purified CS-C, but was unable to detect CS-A (data not shown).  This suggests that the 
CS-56 antibody is unsuitable for use in D. melanogaster, as Drosophila do not synthesize CS-C.   
Anti-chondroitin 4S (clone 2H6) can efficiently detect CS-A (chondroitin-4-sulfate) (Yi et al., 
2012), which is the only type of CS known to be expressed in Drosophila (Sugiura et al., 2012).  
Anti-chondroitin 4S antibodies are available solely from Amsbio and may prove useful in 
quantification of CS synthesis in western blot analysis, as well as have potential applications 
visualizing CS localization in whole-mount embryos in situ. 
The second method whereby I attempted to quantify CS synthesis in Drosophila was by 
DEAE column purification of GAGs followed by chondroitnase digestion and mass spectroscopy.  
To test if genetic manipulation might have an effect upon CS synthesis, 200 embryos were 




maxiumum speed.  The supernatant was passed three times through a 250 ul DEAE sepharose 
column, which binds to negatively charged species such and heparan, chondroitin, and nucleic 
acids.  Columns were washed five times, and eluted in 1.5 M NaCl.  The eluate was desalted in 
an Amicon Ultra tube and then incubated at 37° over night after adding chondroitinase ABC, an 
enzyme that breaks chondroitin chains down into disaccharide components (Prabhakar et al., 
2005).  The samples were then boiled for 1 minute and then spun down for 10 minutes to pellet 
the protein.  The supernatant was then collected and subjected to mass spectroscopy analysis. 
However, no chondroitin sulfate disaccharide parental peaks were observed in the spectra.   
On the third quantification attempt, I utilized a modified protocol employed by Pinto et al. 
in quantifying GAGs in Drosophila embryos (Pinto et al., 2004).  500 embryos were submerged in 
3 ml of acetone and incubated for 12 hours at 4°C.  The acetone was dried off at 60°C, and then 
embryos were suspended in papain buffer (50 mg papain, 5 mM EDTA, and 5 mM cysteine in 10 
ml of water) and incubated for 12 hours at 60°C.  T he embryos were pelleted in a centrifuge 
(2000 x g, 10 minutes, 25°C), and the supernatant was reserv ed.  10 ml of fresh papain buffer 
was added to the pellet, and the same procedure was repeated until 3x10 ml aliquots of 
supernatant were collected.  Supernatants for each sample were pooled, and the GAGs were 
precipitated by addition of 90 ml of ice-cold 95% ethanol.  Samples were incubated for 12 hours 
at 4°C.  Precipitate was collected by centrifugatio n (2000 x g, 10 minutes, 25°C) whereupon the 
supernatant was removed and the precipitate allowed to air-dry.  Samples were resuspended in 1 
ml water and digested overnight with chondroitinase ABC and subsequently analyzed by mass 
spectroscopy.  No chondroitin sulfate-associated parental peaks were detected in the resulting 
spectra.  It is possible that this protocol could be more sensitive if parent flies are fed a diet 
containing Na235SO4, which would cause the embryonic HS and CS to be labeled with 35S.  
Na235SO4 feeding was employed in the original study. 
 
Analysis of Wand function 
Ultimately, loss of function of wand may not lead to a detectable depletion of chondroitin 




encoded by wand and CG9220.  In this case, the phenotype of wand loss of function may be due 
to the specific cardiac-restricted expression of wand during Drosophila dorsal closure.  wand may 
have a specific function in this tissue at this time point above and beyond the function performed 
by general embryonic chondroitin sulfate, which is maternally deposited in high levels into 
oocytes (Pinto et al., 2004).   
Because of the difficulty in assaying the loss of CS directly in wand RNAi embryos, focus 
should be shifted to the biochemical function of the enzyme encoded by wand.  The activity of 
Wand protein can be determined just as the human ChSy1, ChSy2, and ChSy3 were assayed 
(Kitagawa et al., 2001; Yada et al., 2003a, 2003b).  The human homologue of wand, ChSy2, is 
predicted to have a transmembrane domain that places the active site inside the Golgi apparatus 
lumen (Yada et al., 2003a), though at least one splice variant is localized to the mitochondria 
(Kuroda et al., 2012).  The enzyme must be solubilized in order to perform enzymatic activity 
tests.   
To overcome the issues associated with transmembrane localization, a truncated version 
of gene sequence that encodes the active site can be ligated downstream of an insulin targeting 
sequence and Protein A-encoding sequence.  This construct can then be inserted into a plasmid 
and introduced into COS cells.  COS cells expressing the chimeric protein will secrete it into the 
culture medium, and the protein can be purified by passing through a column containing anti-
protein A-coated beads.  Purified chimeric enzyme can then be assayed for enzymatic functions 
in CS synthesis, as described elsewhere (Kitagawa et al., 2001; Yada et al., 2003a, 2003b). 
Wand should be tested for both β1,3-GlcUA transferase and β1,4-GalNAc transferase activities, 
as these are the activities present on homologue Css2 (Yada et al., 2003a). As a negative control 
for this experiment, COS cells would be transformed with a plasmid encoding the insulin targeting 
sequence ligated to the Protein A-encoding sequence; culture supernatant from these cells 
should not have increased β1,3-GlcUA transferase and β1,4-GalNAc transferase activities.  A 
negative control for this experiment would be a plasmid that contained only the insulin targeting 
sequence and Protein A-encoding sequence.  For a positive control, COS cells could be 




to an insulin targeting sequence and a Protein A-encoding sequence, as previously described 
(Yada et al., 2003a). 
 
Proposed methods to test for a physical interaction between CS and Dpp 
 In the previous chapter, it was demonstrated that loss of function of the enzymatic 
machinery required for CS synthesis results in ectopic dpp transcription and expanded Dpp 
signaling.  The exact cause of the dpp/Dpp expansion is unknown at this time, but we have 
proposed that CS acts as an extracellular sink that binds Dpp and interferes with its signaling 
through its receptors.  In order to test this model, an approach to directly test for a physical 
interaction between Dpp and CS is needed. 
 
Procedures for the visualization of Dpp in situ 
Due to the difficulty of raising antibodies to detect Dpp in situ (Lecuit and Cohen, 1998), 
live visualization of Dpp might be accomplished through a Dpp-GFP fusion protein.  Dpp-GFP 
under the transcriptional control of the UAS promoter has been successfully utilized for studies in 
Drosophila to investigate the shape of Dpp gradients in wing discs and how glypicans can alter 
those gradients (Teleman and Cohen, 2000).  However, the existing line is somewhat 
problematic, in that signaling gradients are sensitive, and changes in levels of receptors or 
ligands can both have effects on the shape of the gradient.  In systems where Dpp-GFP is 
induced by Gal4 expression, the Dpp-GFP expressed would be in addition to the endogenous 
locus, and might be sufficient to disrupt the interactions we are trying to observe.  These issues 
might be circumvented by generation of a Dpp-GFP fusion protein that replaces the endogenous 
dpp locus.  Furthermore, eliminating the need for Gal4 to drive UAS:Dpp-GFP expression 
simplifies genetics for further manipulations, or would allow use of the UAS-GAL4 system to drive 







Procedures for the visualization of chondroitin in situ 
Live visualization of chondroitin through GFP-antibody fusion expression 
One novel method used to visualize GAGs in vivo was developed in C. elegans.  The 
worms expressed in their coelomocytes, cells of the innate immune system, a GFP-fused 
antibody specific to particular HS structures (Attreed et al., 2012).  The antibody is secreted from 
the coelomocytes and then accumulates on cells and tissues that have the corresponding HS 
epitope, allowing its localization to be visualized.  Such a system might work in Drosophila to 
detect CS, but potential unanswered questions include where to drive expression of CS (though 
hemocytes might make a good candidate) and what antibodies to use for CS detection.  The lack 
of good antibodies to detect CS in vitro or in vivo in Drosophila requires special attention, but if 
new antibodies are found to work effectively, this could be an effective method to visualize CS 
localization in Drosophila.  The best candidate might be anti-chondroitin-4-sulfate, encoded by 
plasmid 2H6, but this antibody should be tested in vivo for efficient detection of CS, as described 
earlier in this chapter.  Transgenic antibody expression in living animals might not be effective for 
colocalization experiments, as antibody binding to CS is likely to disrupt the ability of CS to 
interact with other extracellular molecules by steric hindrance or competing for binding sites.  
Nevertheless, it may prove useful as a method to analyze the dynamic expression of chondroitin 
sulfate proteoglycans (CSPGs) during Drosophila development. 
 
Vizualization of chondroitin by Staudinger-Bertozzi ligation 
Staudinger-Bertozzi ligation is an additional method whereby CS can be visualized in live 
embryos.  A sugar with a specific azide moiety is introduced into the embryo, where it can be 
incorporated into glycans via the hexosamine salvage pathway.  A triarylphosphine can then be 
conjugated to the azide moiety in a mild reaction that takes place in aqueous solutions (Saxon 
and Bertozzi, 2000).  The azide is incorporated into embryonic CS; it can be ligated to a specific 
FRET-based phosphine with an attached fluorophore and compatible FRET quencher.  Following 
Staudinger ligation, the quencher is released into solution allowing the fluorophore to be turned 




N-azidoacetylgalactosamine, or GalNAz, is the azide moiety that can be utilized to create 
UDP-GalNAz through the GalNAc scavenging pathways (Hang et al., 2003).  In order to enable 
efficient labeling of CS with GalNAz, sufficient substrate must be introduced into the Drosophila 
embryonic cells.  UDP-GlcNAc and UDP-GalNAc (and their azide counterparts) cannot be 
absorbed across the cell membrane due to a negative charge and lack of membrane 
transporters; UDP-GlcNAc is synthesized in the cytoplasm from glucose and is then transported 
into the ER and Golgi through specific transporters which are localized there and then utilized 
there to carry out glycosylation (Perez and Hirschberg, 1985).  UDP-GalNAc can then be 
incorporated into GalNAc-containing glycosylation modifications; GalNAz, if present, can 
substitute for GalNAc in these glycosylmodifications.  There are two methods that might be used 
to introduce GalNAz into embryos.  The first option is feeding GalNAz directly to females, who 
would then incorporate it into oocytes.  If the amount of GalNAz delivered into oocytes in 
insufficient for labeling, then an alternate second option would be to inject GalNAz as a bolus into 
early syncytial blastoderms.  In either case, GalNAz can be utilized to make UDP-GalNAz through 
the GalNAc salvage pathway. 
It is important to note that GalNAz feeding or injection will not solely label CS; though 
GalNAz will be incorporated into CS, it will also be incorporated into mucin-type O-linked 
glycoproteins (Hang et al., 2003).  This may cause difficulty in distinguishing mucin-type O-linked 
glycoproteins from chondroitin sulfate proteoglycans.  However, mucin-type O-linked 
glycoproteins only can incorporate GalNAz in a covalent linkage to hydroxyl group of serine or 
threonine residues (and thus may contain a maximum of one GalNAz per oligosaccharide), 
whereas a CS could contains up to 50% GalNAz, if no other endogenous sources of GalNAc are 
present and GalNAz is used exclusively (Hang and Bertozzi, 2001).  Thus, large differences 








Combination of chondroitin and Dpp visualization  
to determine colocalization 
Physical proximity between chondroitin and Dpp could then be assayed by injecting 
GalNAz into early syncytial blastoderm embryos which have their endogenous Dpp replaced by a 
Dpp-GFP protein as proposed earlier in this chapter.  GFP and the phosphine-attached 
fluorophore must have distinct wavelengths of emission so as to avoid spectral bleed-through. 
One last method might provide in vitro evidence of an interaction between Dpp and CS.  
Previously, binding affinity between Bmp-4 and 4,6-disulfated chondroitin has been assayed 
through fluorescence correlation spectroscopy (Miyazaki et al., 2008).  This microscopy method 
can track movement and diffusion, due to Brownian motion, of fluorescently labeled molecules 
and thus calculate a diffusion coefficient for the molecules.  As proof of principle, in a published 
study the diffusion of fluorescine-labeled 4,6-disulfated chondroitin is slowed when Bmp-4 is 
added to the solution; this indicates a physical interaction between the two molecules (Miyazaki et 
al., 2008).  Fluoresceinamine-labeled sodium chondroitin sulfate A can be obtained from 
Cosmobio Inc. (catalog#CSR-FACS-A1).  Recombinant Dpp can be synthesized and properly 
processed posttranslationally in Chinese hamster ovary cells without likely complications (Israel 
et al., 1992).  In addition to testing for interaction with CS-A, the interaction of Dpp with CS-O 
(unsulfated CS) should also be tested, and research indicates that chondroitin in Drosophila is 
often undersulfated (Pinto et al., 2004). 
 
Proposed chemical, enzymatic, and genetic methods to alter CS synthesis 
Many things could be learned about the role in CS in shaping signaling gradients if there 
were a method to boost and antagonize CS synthesis.  This could provide new insight into 
mechanisms of gradient formation, tissue-specific factors that contribute to gradient shape, and 
other signaling factors which are affected by CS.  CS may play an unappreciated role in Dpp 
signal regulation in other tissues.  This section will discuss methods to alter CS synthesis in vivo, 
the potential applications of these methods, and the potential pitfalls and complications of altering 




Utilizing xylosides to promote and antagonize CS synthesis 
One possibility to investigate the effects of chondroitin sulfate on early Dpp signaling is 
through the use of xylosides.  Heparan and chondroitin formation is initiated by transferring 
glucose or galactose from their corresponding UDP-linked counterparts. Xylosides are glycosides 
that are generated from xylose and can serve as acceptors of glucose or galactose transfer.   In 
1973, it was noted that p-nitrophenyl β-D-xyloside was able to serve as substrate for galactosyl 
transferase I, leading to the initiation of synthesis of free glycosylaminoglycan chains (Okayama 
et al., 1973).  Since this time, xylosides with varying structures have been tested for their ability to 
promote or antagonize chondroitin, heparan, and dermatan synthesis (Cambiazo and Inestrosa, 
1990; Carrino and Caplan, 1994; Fritz et al., 1994; Gibson et al., 1977; Klein et al., 1989; 
Lugemwa et al., 1996; Tsuzuki et al., 2010; Vassal-Stermann et al., 2012).  It is also worth noting 
that any chondroitin or heparan synthesis that is initiated by xylosides will not be bound to a core 
protein, but will be free-floating in the extracellular matrix (or the culture medium, depending on 
the protocol) (Okayama et al., 1973; Sobue et al., 1987).  In choosing a xyloside, factors to 
consider are toxicity, rate of promotion or blocking of CS synthesis, and bleed-over of effects on 
other GAG moieties.  For instance, consider 4-deoxy-4-fluoroxylosides.  4-deoxy-4-
fluoroxylosides have relatively low toxicity, having no negative effects on cells at 300 uM and 
lower concentration (Tsuzuki et al., 2010).  They are effective at blocking GAG synthesis, as they 
lack an acceptor hydroxyl group at C-4 in order to allow enzymatic initiation and extension of 
GAG chains (Tsuzuki et al., 2010).  Thus they serve as competitive inhibitors to extension of 
xylose bound to proteins, and many core proteins will remain naked under 4-deoxy-4-
fluoroxyloside treatment conditions.  These xylosides are effective at blocking both heparan and 
chondroitin synthesis and are ideal in cases where the consequences of total GAG loss are of 
interest.  Considering these four points of xyloside function assists in selecting the proper tool for 
a xyloside assay.  One common pitfall in selecting a xyloside for treatment is to select one with 
low tissue permeability, as some early studies that explored the capabilities of xylosides to accept 
galactose from UDP-galactose were performed in cell-free systems (Robinson and Robinson, 




Also of note, while many xylosides preferentially prime synthesis of CS chains, β-D-
xylosides that have two fused aromatic rings can efficiently prime HS chain synthesis (Fritz et al., 
1994).  Though β-D-xylopyranosides (or O-glycosides) are typically used in order to promote CS 
synthesis, C-xylopyranoside incubation for 14 days increased GAGs found in in the extracellular 
matrix in human fibroblast culture by 15 fold.  C-xylopyranoside may be useful for some 
applications, as it has a higher metabolic stability than traditionally used β-xylosides (Vassal-
Stermann et al., 2012).  In cell culture situations, β-D-xyloside causes the initiation of several CS 
chains that have normal structure and sulfation patterns, in comparison to their CSPG 
counterparts, but differ in that the xyloside-linked CS chains are shorter (Carrino and Caplan, 
1994). 
Despite the strength of xylosides in specifically targeting GAGs, there are some not 
insignificant drawbacks that may complicate their effective use in studying the effects of CS on 
Dpp signaling.  Due to the rapid changes that take place during development, and the fact that 
xyloside treatment would not eliminate CS synthesis but would only eliminate CSPG synthesis, it 
may not be fruitful to pursue xyloside injection in Drosophila embryos.  If chondroitin sulfate is 
truly acting as a sink for Dpp, then it might likely have that same effect whether found in the ECM 
or bound to a CSPG such as Sdc or Trol.  Xylosides may still have some value to study Dpp 
antagonism at later time points, once the free-floating CS has time to clear from the system.  
More data are required to estimate the time required for this clearance to occur in Drosophila. 
That being said, one piece of data about the interaction of Decorin with TGF-beta 
signaling suggests that xyloside treatment may still be worth study. Chinese hamster ovary cells 
are known to produce chondroitin sulfate.  In one experiment, the cells were made to overexpress 
Decorin, which is a chondroitin/dermatan sulfate proteoglycan.  Decorin expression led to a 
decrease in cell growth due to a decrease in TGF-beta signaling.  In fact, it was found that 
Decorin had a strong affinity for TGF-beta.  Interestingly, TGF-beta stimulates expression of 
decorin, suggesting that the CSPG Decorin might be part of a negative feedback pathway for 
TGF-β signaling (Yamaguchi et al., 1990).  The core protein of Decorin itself was found to be 




were presented that suggested that truncation of HS might result in decreased stability of the 
glypican Dally-like.  If this is the case, then xyloside treatment, which causes decreased HS and 
CS synthesis on core proteins, could result in lower stability of those core proteins.  Similar 
mechanisms could also exist for chondroitin sulfate, though I could not find any specific examples 
in the literature. 
 
Utilizing modified xylose to block GAG synthesis 
Xyloside treatment is not the only method whereby embryonic CS can be eliminated.  As 
HS and CS chains are synthesized on xylose, chain synthesis can be blocked by introducing a 
xylose that is incompatible with chain initiation; by this principle, 4-azido-4-deoxyxylose is an 
effective blocker of GAG synthesis.  A chain-terminating 4-azido-4-deoxyxylose can be 
introduced onto core proteins by introducing UDP-4-azido-4-deoxyxylose into the metabolic 
system (Beahm et al., 2014).  Zebrafish embryos injected with 50 pmol of UDP-4-azido-4-
deoxyxylose during the 1–4 stage had a reduction of HS and CS levels by 47 % and 77 %, 
respectively.  Because synthesis of GAG is reduced, there are fewer concerns about issues with 
synthesized GAG chains being cleared from the system, as is the case for xyloside treatment.  
Though the treatment described here is most effective at reducing CS synthesis, a significant HS 
reduction remains, so there is the potential for off-target or confounding effects. 
 
Utilizing chondroitinase ABC to enzymatically destroy CS in vivo 
In order to determine the effects of loss of CS, enzymatic methods of CS digestion may 
be of use.  The most straight-forward approach would involve soaking embryos in a 
chondroitinase ABC solution.  However, though many permeabilization protocols have been 
demonstrated to allow the uptake of small molecules up to 1 kDa in size to be taken up in the 
embryo (Rand et al., 2010), far less is known about the ability of permeabilized embryos to take 
up a molecule of molecular weight 120 kDa such as Chondroitinase ABC.  A method with more 
potential applications and that would allow temporally and spatially restricted analysis of CS 




could be generated by insertion of a modified chondroitinase-encoding plasmid into attP sites 
using a φC31-based integration system (Bischof et al., 2007; Prabhakar et al., 2005). Studies 
have shown that the Chondroitinase ABC I from Proteus vulgaris can be secreted from 
mammalian cell culture when certain N-glycosylation sites are eliminated by site-directed 
mutagenesis (Muir et al., 2010). This mutagenesis may be sufficient in order to allow secretion 
from Drosophila cells as well, but this will need to be tested by transfection in S2 cells. 
 
Increasing CS synthesis through induced expression  
of pathway components 
Chondroitin sulfate serves as a sink in the context of the epidermis, and it may be able to 
function as a sink in other Drosophila tissues.  An ectopic sink for Dpp in the wing disc might be 
created by generating more CS, which could be detected by a reduction of P-Mad localization in 
the wing disc. An area that exhibits long-range Dpp signaling might be altered to short-range Dpp 
signaling when additional CS is introduced into the area.  One way to accomplish this would be 
through overexpression of wand mRNA, leading to a higher concentration of enzyme to catalyze 
synthesis of chondroitin sulfate.  3rd instar wing discs would work well for this experiment, as Dpp 
functions as a long-range signaling in this tissue, and there is no known function for CS in the 
wing disc (Lecuit et al., 1996). However, all of the necessary components, and perhaps some 
other ones, must be present in order for CS synthesis to occur. For instance, an increase in CS 
synthesis in wing discs could not occur due to an increase in wand expression if Gale expression 
is insufficient to provide the additional UDP-GalNAc to meet demand.  A functional increase in CS 
would require the presence of a CSPG in order to be the acceptor of the extending CS chain.  
Additional CSPG core protein expression would also be required if CS is already saturated in the 
wing disc.   
When I attempted this experiment, transcription of UAS:wand under control of 
vestigial:Gal4 could not be detected.  The UAS site was located on the 3’ terminal region of a 
piggyback transposon, designed to allow expression activation of adjacent genes, inserted 




order to proceed with this experiment. 
  
Applications of chondroitin depletion 
Testing if wand RNAi phenotype is due to physical  
interaction with other proteins 
It is possible that the effects seen by wand depletion are not all due to loss of CS 
synthesis.  (Though, in the case of wand it is likely that many of the phenotypes are, due to the 
fact that they are shared with mmy and Gale mutants.)  Several enzymes that are involved in 
GAG synthesis have interactions with other proteins; thus, eliminating a particular enzyme may 
have unintended consequences in other systems that are unrelated to the downstream substrate 
in question.  This has been documented for EXT1 and EXT2, which have function to synthesize 
HS (Senay et al., 2000).  EXT2 catalyzes little to no HS synthesis in the absence of EXT1, but 
both have a synergistic effect when in complex to increase their synthesis beyond the sum of 
their activities (McCormick et al., 2000).  Additionally, when the cytoplasmic tail of Uronosyl 5-
epimerase was altered to change its localization from the Golgi apparatus to endoplasmic 
reticulum, 2-O-sulfotransferase was likewise relocalized (Pinhal et al., 2001).  It is as of yet 
unknown what proteins interact with Wand, but wand mRNA depletion could result in effects in 
other pathways if this prevents proteins that associate with Wand on the Golgi membrane to fail 
to assemble.  Utilizing either xylosides, a xylose analog, or CS-ABC to eliminate CS synthesis 
could answer the question whether the effects of wand loss of function on Dpp signaling are due 
to CS itself, or due to a possible confounding effect due to Wand being part of a protein complex. 
 
Creating a de novo CS sink, or destroying an in vivo sink 
Dpp signaling range varies dependent upon tissue and developmental time point in 
different Drosophila tissues.  In the embryonic dorsolateral epidermis, as I have described here, 
Dpp signals at a short range.  Long range signaling has been extensively studied in larval 
imaginal discs, where different concentrations of Dpp result in differential gene expression (Nellen 




testes and ovary (Kawase et al., 2004; Shivdasani and Ingham, 2003; Song et al., 2004); Mad is 
phosphorylated in germline stem cells and gonialblasts, but remains unphosphorylated in all other 
cells of the testis (Kawase et al., 2004).   
Dpp is made in the somatic hub cells, and P-Mad is observed in the adjacent germline 
stem cells.  In order to test if the short-range localized Dpp signaling is a result of chondroitin 
sulfate acting as a Dpp sink, RNAi against wand and/or CG9220 can be performed in the testes, 
followed by analysis for expansion of P-Mad regions.  wand and CG9220 are mostly absent from 
testes of 4 day old mated males (Celniker et al., 2009).  However, it is of note that P-Mad 
detection in adult testes is strongest during the first 48 hours after adult flies eclose (Chang et al., 
2013), so any major requirement for CS in the testes would most likely be seen earlier than day 4 
after eclosion.  mmy, Gale, and sdc have moderate expression in testes, while expression of trol 
remains low (Celniker et al., 2009).  Because of the potentially redundant functions of wand and 
CG9220 in CS synthesis, ideally both would be depleted with RNAi.  Alternately, tissue-specific 
expression of chondroitinase ABC, as described earlier in this chapter, could be utilized.  
Chondroitinase ABC should be used with caution, as its diffusion in the extracellular space could 
suggest cell nonautomomous effects on systems that are autonomous.  The CS sink could be 
present in one of several potential cell types (functioning as a cell autonomous or a cell 
nonautonomous sink).  To this end, the UAS-Gal4 system could be used to induce tissue-specific 
depletion of chondroitin sulfate to determine which cell type(s) are important in Dpp signal 
antagonism in the testes.  Depletion could be accomplished by wand shRNA expression or by 
expression of chondroitinase ABC.  Depletion in germline stem cells could be accomplished 
under the control of nanos-Gal4-VP16 (Van Doren et al., 1998). Depletion in hub cells can be 
accomplished by Upd-Gal4 expression of shRNA (Zeidler et al., 1999) and cyst stem cells and 
cyst cells by using ptc-Gal4 (Tazuke et al., 2002).  
 
CSPGs of particular interest in Drosophila 
There are four CSPGs that are known to be expressed in the embryonic Drosophila heart 







Multiplexin (Mp) is a homologue of human collagens XV and XVIII, which are 
heparan/chondroitin sulfate proteoglycans; failure of the Drosophila protein to shift in gel after 
incubation with heparitinase suggests that it is CS modified only (Momota et al., 2011).  Mp 
localizes primarily to the basement membrane of cells and is prominently expressed in many 
tissues, including the cardioblasts of the heart during embryonic stage 16. mp hypomorphs have 
phenotypes associated with Wg signaling failure, including wing defects, absence and/or 
abnormal fusion of tergites in the adult abdomen, and abnormal deposition of Wg protein itself in 
the provetriculus (Momota et al., 2011).  Multiplexin is expressed in the cardiac cells near the time 
of dorsal closure completion and is thus not likely to play a large role in Dpp regulation during 
dorsal closure.   
 
Terribly reduced optic lobes 
terribly reduced optic lobes (trol) was named due to the reduction in imaginal disc size 
and abnormal brain morphology (Datta and Kankel, 1992).  trol mRNA is expressed strongly in 
stage 15 embryonic cardiac cells (Friedrich et al., 2000). Trol is found in the extracellular matrix 
around the Drosophila lymph gland (Grigorian et al., 2013).  Human Perlecan core protein binds 
to FGF7 ligand, and HS modification is dispensable for this modification (Mongiat et al., 2000). 
 
Syndecan 
Syndecan comes from the Greek “syndein,” which means “to bind together”; syndecan 
binds to growth factors and extracellular matrix extracellulary and intracellularly to actin (Bernfield 
et al., 1992).  All syndecans are heparan sulfate proteoglycans, but many syndecans, including 
those found in Drosophila, also have attached chondroitin sulfate (Chanana et al., 2009; Gould et 
al., 1992; Rapraeger et al., 1985).  Ligands that are bound to syndecan can be released into the 




cell surface receptors (Bernfield and Hooper, 1991; Kato et al., 1998). 
Syndecans have been well characterized for their roles in migration of axons and cells in 
D. melanogaster and C. elegans (Johnson et al., 2004; Minniti et al., 2004; Rhiner et al., 2005; 
Smart et al., 2011; Steigemann et al., 2004).  Axonal migration defects are primarily due to the 
role of syndecan in Slit/Robo signaling (Chanana et al., 2009; Johnson et al., 2004; Steigemann 
et al., 2004).  There have been few studies documenting the role of syndecan on early 
development.   
 
Kon-Tiki 
The CSPG kon-tiki, the Drosophila homologue of CSPG4, is expressed in the dorsal 
vessel during dorsal closure in a shared pattern with wand (Hammonds et al., 2013; Tomancak et 
al., 2002, 2007).  Though it has been studied for its role in myofiber targeting and muscle 
specification, potential roles in heart development and signal regulation have not been addressed 
(Pérez-Moreno et al., 2014; Schnorrer et al., 2007; Wolfstetter and Holz, 2012). 
These four CSPGs, and any others which are discovered to play a role in the Drosophila 
heart, should be the focus of ongoing studies to determine the particular CSPG(s) that antagonize 











ADDITIONAL EXPERIMENTS OF NOTE 
 
Tests for transcriptional regulation by P-Jun homodimers in vivo 
 Multiple lines of evidence suggest that Jun is able to homodimerize in the absence of Fos 
protein and bind to AP-1 binding sites (Halazonetis et al., 1988; Smeal et al., 1989).  A caveat, 
however, to these experiments and similar experiments, is they are performed in cell culture, in 
cell free systems, or rely upon overexpression of Jun.  Whether homodimerization of Jun at 
endogenous expression levels is able to activate gene expression remains unknown.  In an 
attempt to extend tissue culture studies of Jun to animal models, I examined whether Jun-
dependent transcription can occur in the absence of its partner, Fos.   
To test whether excess Jun activity can compensate for the loss of Fos (consistent with 
the idea that in some contexts Jun homodimers might be bioactive), I examined the cuticle 
phenotypes of puc1kay1 double mutant embryos.  kayak (kay) encodes the Drosophila homologue 
of Fos, and dimerizes with Jun to form the active AP-1 transcription factor that drives dpp 
transcription in the epidermis (Zeitlinger et al., 1997).  In the Drosophila dorsal epidermis during 
dorsal closure, kay null mutants do not have active Jun-dependent transcription, as evidenced by 
a failure to transcribe leading-edge dpp (Zeitlinger et al., 1997).  puckered (puc) encodes a Jun 
phosphatase, and mutants have increased bioactive P-Jun in the epidermis (Martín-Blanco et al., 
1998).  Thus, puc1kay1 embryos have an abundance of P-Jun due to loss of the Puc 
phosphatase, as well as an absence of AP-1, due to lack of Fos.  puc1kay1 mutant embryos were 
collected and aged, and larval cuticle phenotypes were visualized after mounting in one-step 
mounting medium (30% CMCP-10, 13% lactic acid, 57% glacial acetic acid).  puc1kay1 cuticles 





Figure 5.1 Jun homodimers transcribe dpp in vivo.  A) A cuticle from a wild-type larva.  B) 
kay1 cuticles are dorsal open and denticled on their ventral surface due to absences of Jun and 
Dpp activity.  C)  puc1 cuticles are dorsally puckered with hypotrophy of ventral denticle belts due 
to overactive Jun signaling and ectopic Dpp signaling.  D) puc1kay1 double mutant embryos 
secrete a cuticle resembling that of puc1 embryos, suggesting that Jun is able activate Dpp 




requires epidermal Dpp transcription, these data suggest that dpp is still transcribed in the 
epidermis of puc1kay1 embryos.  That the puc kay phenotype is not analogous to the kay 
phenotype suggests that the phenotype can arise from P-Jun acting on its own to enact 
transcription in the absence of Fos.  Moreover, these data support a model wherein P-Jun can 
homodimerize and drive transcription in vivo, but only under conditions in which Jun 
phosphorylation levels are elevated.  The next step in this evaluation of function of Jun 
homodimers in transcriptional activation is to examine the localization of dpp transcription in 
puc1kay1 embryos. 
 
Tests of Dpp autoregulation using the dpp151H enhancer trap 
Dpp expression is autoregulatory in various tissues, including imaginal disks and the 
midgut (Chanut and Heberlein, 1997; Yu et al., 1996). The disk region of the dpp gene lies in the 




expression of the dpp transcript (St Johnston et al., 1990). The disk region enhancer trap dpp151H 
is reported to detect autoregulatory dpp expression in the Drosophila embryo through lacZ 
expression (Johnson et al., 2003; Smith et al., 1993). mmy and members of the CS synthesis 
pathway plays a role in antagonizing Dpp signal transduction and autoregulation, and thus we 
suspected that the dpp151H enhancer trap might be a useful reagent for measuring signaling 
capacity in the epidermis of CS pathway mutants  (Humphreys et al., 2013; Chapter 3).   
 To test the validity of this approach, I probed the expression of the enhancer trap dpp151H 
in wt, mmy1, and rawIG backgrounds.  Expression of the dpp151H enhancer trap was visualized 
utilizing alkaline phosphatase immunolocalization methods; mouse anti-β-Gal (1:500, Promega) 
and goat anti-mouse alkaline phosphatase (1:2000, Promega) were utilized, as described 
(Sullivan et al., 2000).  In wt embryos, β-Gal was expressed in the leading edge of the epidermis, 
as previously published (Figure 5.2A) (Johnson et al., 2003).  Curiously, however, I saw no 
expansion of dpp151H enhancer trap in the dorsolateral epidermis of mmy1 mutants (with 
hyperactive Dpp-dependent dpp transcription) (Figure 5.2B). Moreover, in raw embryos (with 
hyperactive Jun-dependent dpp transcription) a striking expansion of β-Gal expression in the 
dorsolateral epidermis was clear (Figure 5.2C).  Together these data indicate that dpp151H 
functions as a Jun reporter in the epidermis, rather than as a Dpp reporter. 
 To test the possibility that dppH151 is a reporter of Jun signaling activity, dppH151 
expression should be assayed in UAS-dpp transgenic animals in which dpp expression is driven 
by the embryonic epidermal driver 69B-Gal4 (Brand and Perrimon, 1993); this analysis should be 
performed in wild-type and Jra mutant backgrounds (Jra encodes Drosophila Jun).  If dpp151H is a 
reporter of Dpp autoregulation, the reporter will turn on in response to UAS-dpp expression in the 
dorsal epidermis whether or not Jun is present.  If dpp151H is a Jun reporter, the reporter will still 
turn on in a punt or thickveins mutant background (where the Dpp signal cannot be transduced, 
and thus autoregulation could not occur) (Brummel et al., 1994; Letsou et al., 1995); this would 







Figure 5.2.  dpp151H expression is restricted to the leading edge in mmy mutants.  (A)  
Expression of the dpp151H enhancer trap in wt embryos.  In this background, expression is 
restricted to the leading edge of the epidermis.  (B)  In mmy1 mutants, the wt expression pattern 




The role of super sex-combs in Dpp signaling antagonism 
In the RNAi screen for glycosyltransferases that antagonize Dpp signaling (described in 
Chapter 3), I identified  super sex-combs (sxc), which encodes the Drosophila O-linked N-
acetylglucosamine transferase, as a Dpp signaling antagonist.  Sxc carries out reversible O-
linked transfer of single GlcNAc onto serine/threonine residues in Drosophila (Sinclair et al., 
2009). 
Drosophila sxc is member of the Polycomb group, and the gene was originally 
characterized as a regulator of Hox gene expression (Gambetta et al., 2009; Ingham, 1984; 
Sinclair et al., 2009).  sxc is recruited to Polycomb group targets on polytene chromosomes, and 
high levels of O-GlcNAc are also observed on chromosome-associated proteins in these same 
regions (Sinclair et al., 2009).  It is of note that neither sxc recruitment nor O-GlcNAcylation is a 
prerequisite for assembly of Polycomb group proteins on chromosomal sites; assembly continues 
in the absence of sxc and O-GlcNAc (Sinclair et al., 2009).  
To test for the role of Sxc in Dpp antagonism, early, ubiquitous sxc shRNA was driven 
under the control of Tubulin:Gal4 (described in Chapter 3).  The UAS:shRNA line utilized was line 
v18610 from the Vienna Drosophila RNAi collection (Dietzl et al., 2007).  Cuticles were analyzed 
for phenotypes suggesting a role in Dpp antagonism.  I noted that the larval cuticle phenotype of 
sxc shRNA embryos is similar to that of the raw group Dpp signaling antagonists (including mmy), 
in that there is a dorsal pucker, germband retraction defect, and hypotrophy of the ventral denticle 





Figure 5.3.  sxc loss-of-function cuticle phenotype results from ectopic Dpp signaling.  (A) 
mmy1 mutant cuticles have a cuticle characterized by a dorsal pucker, a germband retraction 
defect, and hypotrophy of the ventral denticles.  (B) sxc RNAi in embryos results in a mmy-like 
loss-of-function phenotype.  (C) wt and (D) sxc RNAi embryos have restricted dpp transcription in 
the epidermis, unlike the expansion seen in mmy1 embryos (see Figure 3.1K).  (E) Dpp signaling 
activity, measured by P-Mad, is found near the leading edge in wt embyros, (F) but is expanded 
in the dorsolateral epidermis in sxc RNAi embryos.  This suggests the sxc RNAi cuticle 




This cuticle phenotype suggested that sxc RNAi embryos might have an increase in dorsolateral 
epidermal Dpp signaling (Humphreys et al., 2013).  To test this I probed Mad phosphorylation, as 
P-Mad is the transducer of Dpp signaling (Hoodless et al., 1996).  I noted that, while epidermal 
Dpp signaling is mostly abolished in stage 13 wt embyros, sxc RNAi embryos have Dpp signaling 
expanded beyond the leading edge into the dorsolateral epidermis, not dissimilar to what we 
observe from raw and mmy mutants (see Figures 2.4F and 3.1K) (Byars et al., 1999).  Next, I 
tested if this cuticle phenotype was associated with ectopic dpp transcription by probing dpp 
mRNA in stage 13 embryos.  Unexpectedly, dpp mRNA remains restricted to the leading edge of 
the epidermis, whereas previously I have only observed epidermal Dpp signaling expansion in the 
presence of ectopic dpp (Humphreys et al., 2013).  These data suggest that sxc loss of function 
results in Dpp signaling expanding from the transcriptional source, but its level is not sufficient to 
activate all its transcriptional targets (e.g., dpp). 
It is highly likely that mmy loss of function would have an impact on intracellular O-
GlcNAc levels.  There is some evidence that when UDP-GlcNAc levels are depleted, intracellular 
O-GlcNAc levels will be more sensitive to a reduction than other glycosylation processes.  When 
UDP-GlcNAc was disrupted in MEF cell culture by EMeg32 knockout, cytoplasmic and nuclear O-
GlcNAc levels were more affected than other glycosylmodifications (Boehmelt et al., 2000).  
Supplementing the cells with additional GlcNAc via culture medium led to restoration of wild-type 
cytoplasmic O-GlcNAc levels and elimination of growth defects (Boehmelt et al., 2000).  The case 
of sxc modulation of Dpp signaling sensitivity is intriguing because it is biochemically downstream 
of mmy, and yet does not have dpp expansion. The O-GlcNAcylated target must be intracellular 
(as Sxc only modifies intracellular targets) and must be no further downstream in the signaling 
pathway than Mad itself (as the phenotype is manifest at this point).  This leaves very few well-
characterized potential targets, being Mad, Tkv, and Punt.  As O-GlcNAcylation can be mutually 
exclusive to phosphorylation (Comer and Hart, 2001), O-GlcNAc may be another method present 
in the Drosophila embryo to prevent small amounts of Dpp from enacting a strong Dpp signaling 
response.  Further research characterizing the signaling components that are specifically 




in the lab. 
 
Characterization of CG33181, a potential Dpp antagonist 
 In 2002, Alain Vincent’s lab group published the results of an X-chromosome P-insertion 
mutagenesis screen isolating and localizing mutants that are homozygous lethal (Bourbon et al., 
2002).  One of the mutants generated in this screen, CG33181PL112, had a cuticle phenotype with 
hypotrophy of the ventral denticles.  As hypotrophy of the ventral denticle belts is a phenotypic 
characteristic of members of the raw group on JNK and/or Dpp signaling antagonists, I obtained 
this mutant line from the investigators to characterize its effects on JNK and Dpp antagonism.  In 
cuticle preparations, I noted that there was a fully penetrant hypotrophy of the ventral denticles, 
though some denticles still remained; thus, the phenotype is similar to what we observe in several 
mmy mutant alleles, including mmyLM16 embryos (Figures 5.4A and 5.4B). Additionally, what the 
investigators identified as “melanotic patches found in salivary glands” are similar to stable 
salivary gland structures that form in many different mmy mutant background, including mmyLM16 
embryos.  As the hypotrophy of ventral denticles is a hallmark of ectopic dpp in the epidermis 
(Bates et al., 2008; Byars et al., 1999; Humphreys et al., 2013), I obtained the CG33181PL112 
mutant line in order to characterize its dpp-associated phenotypes. 
 CG33181PL112 mutants maintain normally restricted dpp transcription in the epidermal 
leading edge and are indistinguishable from wild-type embryos (Figures 5.4C and 5.4D).  
However, two points are worth consideration to understand this phenotype.  First, multiple mmy 
alleles that have similar cuticle phenotypes to CG33181PL112 mutants do not have ectopic dpp 
transcription (data not shown).  Second, the cuticle phenotype of denticle hypotrophy can result 
from increased Dpp signaling, even if dpp transcription remains unaffected.  This conclusion is 
supported by my experiments on loss of function of sxc (Sinclair et al., 2009); embryonic sxc 
RNAi results in expanded Mad phosphorylation in the dorsolateral epidermis, even though dpp 
transcription remains restricted to the leading edge of the epidermis (Figures 5.3D and 5.3F).  
Research into the mechanism of the expansion of P-Mad in sxc loss-of-function embryos is 





Figure 5.4.  Phenotypic characteristics of CG33181PL112 mutant embryos.  (A) mmyLM16 
cuticles exhibit hypotrophy of ventral denticle belts.  Also of note is the acid-resistant salivary 
gland remnant (A’) denoted with a white arrow.  (B) CG33181PL112 mutant cuticles similarly exhibit 
hypotrophy of ventral denticle belts and (B’) acid-resistant salivary gland remnants.  (C) Wild-type 
and (D) CG33181PL112 mutant embryos have dpp restricted to the leading edge, indicating that 
CG33181 does not antagonize dpp transcription.  All cuticles are shown in ventral views, and 




though dpp transcription itself appears unaffected.  Mad phosphorylation should be examined in 
CG33181PL112 mutant embryos to determine if it has expanded Dpp signaling activity, in a similar 
manner. 
 The protein encoded by CG33181 is homologous to human SLC41A2 (Solute carrier 
family 41, member 2), a membrane-embedded divalent cation transporter.  This protein can 
transfer Mg2+ and Mn2+ across cell plasma membranes (Sahni et al., 2007).  This is not the first 
ionic channel with potential effects on Dpp signaling; Dpp signaling in Drosophila wing discs is 
reduced when the K+ channel Irk2 function is depleted (Dahal et al., 2012).  It is intriguing to 




Drosophila homologue of Protein phosphatase magnesium-dependent 1A (PPM1A).  PPM1A  is 
a phosphatase which requires Mg2+ for activity (Duan et al., 2006; Lin et al., 2006).  PPM1A 
antagonizes Mad via removal of phosphate groups, resulting in the inactivation of Mad and its exit 
from the nucleus.  Thus, loss of cellular Mg2+ could result in loss of PPM1A activity and thus a 
higher level of Mad phosphorylation in response to wild-type levels of Dpp. 
 
Tests for the role of mmy in Wingless signal regulation  
during embryonic development 
The glypicans Dally and Dally-like regulate multiple signaling factors during  Drosophila 
development, including Wingless (Wg) and Hedgehog (Hh) (Akiyama et al., 2008; Desbordes and 
Sanson, 2003; Gallet et al., 2008; Lin and Perrimon, 1999; Wu et al., 2010; Yan et al., 2009). As 
mmy is required for synthesis of the heparan sulfate attachments on glypicans, I hypothesized 
that mmy loss of function may have an effect on embryonic Wg and Hh signaling.  To test for 
disruptions in epidermal Wg, which helps define segment polarity, I examined embryonic 
localization of Engrailed and Even-skipped in whole mount embryo immunolocalization studies 
(4D9 and 2B8, DSHB).  Wg and Hh signaling contribute to the establishment and maintenance of 
En expression in organized segmental epidermal stripes (Figure 5.5A).  Embryonic En pattern 
was compared among wild-type, wg, and two mmy mutant alleles, mmyLM24 and mmyLM47 
embryos.  In wg mutants, there is a decay of En expression in the epidermis, with the only 
remaining protein seen in the extreme ventral ectoderm (Figure 5.5B).  There was no difference 
between the En pattern observed between wild-type embryos and mmy mutants (Figures 5.5A, 
5.5C, and 5.5D).  These data suggest that mmy does not play a role in Wg pattern regulation in 
the ventral epidermis.  I examined Eve expression as well to determine if mmy was required for 
Wg signaling in the dorsal epidermis; definition of the Eve cells of the dorsal mesoderm requires 
proper Wg and Hh patterning for correct specification (Figures 5.5E and 5.5F) (Wu et al., 1995).  
The loss or gain of Eve-expressing pericardial cells in the dorsal mesoderm would indicate that 
mmy is required for Wg regulation dorsally; this region is near the area where mmy regulates Dpp 





Figure 5.5.  mmy loss of function does not affect embryonic Wg and Hh signaling.  (A) 
Engrailed (En) is expressed in segmental epidermal stripes in wt embryos.  (B) wg mutants lose 
most of the epidermal En expression.  (C) There are no En expression abnormalities in (C) 
mmyLM24 and (D) mmyLM47 mutants, suggesting mmy loss of function does not affect Wg signaling 
in the epidermis.  (E) Proper Wg and Hh signaling are required to properly specify the Eve-
expressing pericardial cells of the ventral mesoderm (white arrows) in wt embryos.  (F)  hhAC 
mutants have disrupted Wg signaling in the mesoderm; as a result, the Eve-expressing 
pericardial cells are not specified.  (G)  Eve-expressing pericardial cells are properly specified in 
the mesoderm of (C) mmyLM24 and (D) mmyLM47 mutants, suggesting mmy loss of function does 
not affect Wg signaling in the mesoderm.  (I)  Wg signaling is required for the formation of three 
distinct invaginations (black arrows) of the primordial stomatogastric nervous system (González-
Gaitán and Jäckle, 1995).  These structures form properly in (C) mmyLM24 and (D) mmyLM47 





mispatterning of Eve-expressing pericardial cells in the dorsal epidermis in mmy mutants, 
suggesting that mmy does not regulate Wg signaling in the dorsal epidermis.   
To test for disruptions in Wg in a polarity-independent function, I examined the 
development of the stomatogastric nervous system (SNS) by visualizing it with anti-Crumbs 
antibody (Cq4, DSHB) (Figure 5.5I).  SNS development is Wg-dependent but independent of 
segment polarity (Häcker et al., 1997).  I observed no defects in the SNS in any of the mmy 
mutant lines tested (Figures 5.5J and 5.5K), indicating mmy loss does not influence Wg signaling 
in SNS development. 
 The lack of Wg-associated phenotypes in mmy mutants is surprising.  It is known that the 
glypicans Dally and Dally-like are required for proper Wg and Hh patterning in the ventral 




Dally or Dally-like results in cuticle defects due to aberrations in segment polarity.  It is also 
known from my analysis of Dally-like by western blot (see Chapter 3) that mmy mutants have a 
decrease in both HS synthesis and a decrease in Dally-like protein.  These data suggest that, 
though there is a decrease in both HS and Dlp in mmy mutants, there is not a sufficient decrease 
in order to significantly affect Wg and Hh signaling.  Even a null allele of dlp does not have a wg-
like mutant phenotype, but only exhibit wg-like cuticle phenotypes when depleted by RNAi 
(Desbordes and Sanson, 2003).  Maternal and zygotic loss of function of mmy may be required to 
elicit an effect on Wg and/or Hh signaling.  Even the reduced level of UDP-GlcNAc in mmy 
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